26
|
Gagliardi T, Bishop B, Battisti N, Rusby J, Ring A, Nash T, Allen M, Downey K, Nerurkar A, Tasoulis M. Microcalcifications after neoadjuvant chemotherapy for breast cancer in women achieving pathologic complete response of the invasive disease: do they matter? Breast 2021. [DOI: 10.1016/s0960-9776(21)00184-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
27
|
Ohaida K, Allen M, Goom J, Marshall J, Jones L. Relationship between altered myoepithelial phenotype and the inflammatory cell infiltrate in progression of DCIS. Breast 2021. [DOI: 10.1016/s0960-9776(21)00128-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
28
|
Gray GE, Bekker LG, Laher F, Malahleha M, Allen M, Moodie Z, Grunenberg N, Huang Y, Grove D, Prigmore B, Kee JJ, Benkeser D, Hural J, Innes C, Lazarus E, Meintjes G, Naicker N, Kalonji D, Nchabeleng M, Sebe M, Singh N, Kotze P, Kassim S, Dubula T, Naicker V, Brumskine W, Ncayiya CN, Ward AM, Garrett N, Kistnasami G, Gaffoor Z, Selepe P, Makhoba PB, Mathebula MP, Mda P, Adonis T, Mapetla KS, Modibedi B, Philip T, Kobane G, Bentley C, Ramirez S, Takuva S, Jones M, Sikhosana M, Atujuna M, Andrasik M, Hejazi NS, Puren A, Wiesner L, Phogat S, Diaz Granados C, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, McElrath MJ, Gilbert PB, Janes H, Corey L. Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults. N Engl J Med 2021; 384:1089-1100. [PMID: 33761206 PMCID: PMC7888373 DOI: 10.1056/nejmoa2031499] [Citation(s) in RCA: 127] [Impact Index Per Article: 42.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
BACKGROUND A safe, effective vaccine is essential to eradicating human immunodeficiency virus (HIV) infection. A canarypox-protein HIV vaccine regimen (ALVAC-HIV plus AIDSVAX B/E) showed modest efficacy in reducing infection in Thailand. An analogous regimen using HIV-1 subtype C virus showed potent humoral and cellular responses in a phase 1-2a trial in South Africa. Efficacy data and additional safety data were needed for this regimen in a larger population in South Africa. METHODS In this phase 2b-3 trial, we randomly assigned 5404 adults without HIV-1 infection to receive the vaccine (2704 participants) or placebo (2700 participants). The vaccine regimen consisted of injections of ALVAC-HIV at months 0 and 1, followed by four booster injections of ALVAC-HIV plus bivalent subtype C gp120-MF59 adjuvant at months 3, 6, 12, and 18. The primary efficacy outcome was the occurrence of HIV-1 infection from randomization to 24 months. RESULTS In January 2020, prespecified criteria for nonefficacy were met at an interim analysis; further vaccinations were subsequently halted. The median age of the trial participants was 24 years; 70% of the participants were women. The incidence of adverse events was similar in the vaccine and placebo groups. During the 24-month follow-up, HIV-1 infection was diagnosed in 138 participants in the vaccine group and in 133 in the placebo group (hazard ratio, 1.02; 95% confidence interval, 0.81 to 1.30; P = 0.84). CONCLUSIONS The ALVAC-gp120 regimen did not prevent HIV-1 infection among participants in South Africa despite previous evidence of immunogenicity. (HVTN 702 ClinicalTrials.gov number, NCT02968849.).
Collapse
|
29
|
Mpofu R, Otwombe K, Mlisana K, Nchabeleng M, Allen M, Kublin J, McElrath MJ, Bekker LG, Churchyard G, Gray G, Laher F. Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial. PLoS One 2021; 16:e0241708. [PMID: 33481787 PMCID: PMC7822320 DOI: 10.1371/journal.pone.0241708] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Accepted: 10/18/2020] [Indexed: 11/18/2022] Open
Abstract
Benign ethnic neutropenia (BEN) is defined as a neutrophil count of <1.5×109 cells/L in healthy individuals and is more common in populations of certain ethnicities, e.g. African or Middle Eastern ethnicity. Neutrophil values are commonly included in eligibility criteria for research participation, but little is known about the relationship between BEN, HIV acquisition, and the occurrence of adverse events during clinical trials. We investigated these relationships using data from an HIV vaccine efficacy trial of healthy adults from 5 South African sites. We analysed data from the double-blind, placebo-controlled, randomized trial HVTN 503, and its follow-on study HVTN 503-S to assess the prevalence of BEN, its association with HIV infection, and adverse event reporting. These data were then compared with a time- and age-matched, non-pregnant cohort from the National Health and Nutrition Examination Survey (NHANES) conducted between 2007–2008 in the United States (US). The 739 South African participants had a median age of 22.0 years (interquartile range = 20–26) and 56% (n = 412) were male. Amongst the US cohort of 845 participants, the median age was 26 (IQR: 21–30) and the majority (54%, 457/745) were also male. BEN was present at enrolment in 7.0% (n = 52) of South African participants (6% in the placebo group versus 8% in the vaccine group); 81% (n = 42) of those with BEN were male. Pretoria North had the highest prevalence of BEN (11.6%, 5/43), while Cape Town had the lowest (0.7%, 1/152). Participants with BEN had a lower median neutrophil count (1.3 vs. 3.2x109 cells/L; p<0.001) and BMI (20.8 vs. 22.3 kg/m2; p<0.001) when compared to those without BEN. A greater proportion of Black South Africans had neutrophil counts <1.5×109 cells/L compared to US non-Hispanic Whites from the NHANES cohort (7% [52/739] vs. 0.6% [3/540]; p<0.001). BEN did not increase the odds for HIV infection (adjusted odds ratio [aOR]: 1.364, 95% confidence interval [95% CI]: 0.625–2.976; p = 0.4351). However, female gender (aOR: 1.947, 95% CI: 1.265–2.996; p = 0.0025) and cannabis use (aOR: 2.192, 95% CI: 1.126–4.266; p = 0.0209) increased the odds of HIV acquisition. The incidence rates of adverse events were similar between participants in the placebo group with BEN, and those without: 12.1 (95% CI: 7.3–20.1) vs. 16.5 (95% CI: 14.6–18.7; p = 0.06) events per 100 person-years (py) were noted in the infections and infestations system organ class, respectively. The vaccine group had an event incidence rate of 19.7 (95% CI: 13.3–29.2) vs. 14.8 (95% CI: 13.0–16.8; p = 0.07) events per 100py in the group with, and without BEN, respectively. BEN is more prevalent in Black South Africans compared to US Non-Hispanic Whites. Our data do not support excluding populations from HIV vaccine trials because of BEN. BEN was not associated with increased risk for HIV infection or Adverse events on a vaccine trial. Predictors of HIV infection risk were females and cannabis use, underlying the continued importance of prevention programmes in focusing on these populations.
Collapse
|
30
|
Oganezova K, Fontana-Martinez EJ, Gothing JA, Pandit A, Kwara E, Yanosick K, Dragavon J, Goecker EA, Maenza J, Espy N, Tomaka F, Lavreys L, Allen M, D'Souza P, Hural J, Coombs RW, Dolin R, Seaman MS, Walsh SR, Baden LR. Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees. Open Forum Infect Dis 2020; 8:ofaa606. [PMID: 33511233 PMCID: PMC7813203 DOI: 10.1093/ofid/ofaa606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Accepted: 12/10/2020] [Indexed: 12/03/2022] Open
Abstract
Background Experimental human immunodeficiency virus (HIV)-1 vaccines frequently elicit antibodies against HIV-1 that may react with commonly used HIV diagnostic tests, a phenomenon known as vaccine-induced seropositivity/seroreactivity (VISP/VISR). We sought to determine, under clinic conditions, whether a patient-controlled HIV test, OraQuick ADVANCE Rapid HIV-1/2 Antibody Test, detected HIV-1 vaccine-induced antibodies. Methods Plasma assessment of HIV-1 cross-reactivity was examined in end-of-study samples from 57 healthy, HIV-uninfected participants who received a candidate vaccine that has entered Phase 2B and 3 testing. We also screened 120 healthy, HIV-uninfected, unblinded HIV-1 vaccine participants with VISP/VISR for an assessment using saliva. These participants came from 21 different parent vaccine protocols representing 17 different vaccine regimens, all of which contained an HIV-1 envelope immunogen. OraQuick ADVANCE was compared with results from concurrent blood samples using a series of commercial HIV screening immunoassays. Results Fifty-seven unique participant plasma samples were assayed in vitro, and only 1 (1.8%) was reactive by OraQuick ADVANCE. None of the 120 clinic participants (0%; 95% confidence interval, 0% to 3.7%) tested positive by OraQuick ADVANCE, and all were confirmed to be uninfected by HIV-1 viral ribonucleic acid testing. One hundred eighteen of the 120 (98.3%) participants had a reactive HIV test for VISP/VISR: 77 (64%) had at least 1 reactive fourth-generation HIV-1 diagnostic test (P < .0001 vs no reactive OraQuick ADVANCE results), and 41 (34%) only had a reactive test by the less specific third-generation Abbott Prism assay. Conclusions These data suggest that this widely available patient-controlled test has limited reactivity to HIV-1 antibodies elicited by these candidate HIV-1 vaccines.
Collapse
|
31
|
White PM, Ford GA, James M, Allen M. Regarding thrombectomy centre volumes and maximising access to thrombectomy services for stroke in England: A modelling study and mechanical thrombectomy for acute ischaemic stroke: An implementation guide for the UK. Eur Stroke J 2020; 5:451-452. [PMID: 33598565 PMCID: PMC7856595 DOI: 10.1177/2396987320971126] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
32
|
Borgersen J, Vines L, Frodason YK, Kuznetsov A, von Wenckstern H, Grundmann M, Allen M, Zúñiga-Pérez J, Johansen KM. Experimental exploration of the amphoteric defect model by cryogenic ion irradiation of a range of wide band gap oxide materials. JOURNAL OF PHYSICS. CONDENSED MATTER : AN INSTITUTE OF PHYSICS JOURNAL 2020; 32:415704. [PMID: 32756022 DOI: 10.1088/1361-648x/abac8b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Accepted: 08/05/2020] [Indexed: 06/11/2023]
Abstract
The evolution of electrical resistance as function of defect concentration is examined for the unipolarn-conducting oxides CdO,β-Ga2O3, In2O3, SnO2and ZnO in order to explore the predictions of the amphoteric defect model. Intrinsic defects are introduced by ion irradiation at cryogenic temperatures, and the resistance is measured in-situ by current-voltage sweeps as a function of irradiation dose. Temperature dependent Hall effect measurements are performed to determine the carrier concentration and mobility of the samples before and after irradiation. After the ultimate irradiation step, the Ga2O3and SnO2samples have both turned highly resistive. In contrast, the In2O3and ZnO samples are ultimately found to be less resistive than prior to irradiation, however, they both show an increased resistance at intermediate doses. Based on thermodynamic defect charge state transitions computed by hybrid density functional theory, a model expanding on the current amphoteric defect model is proposed.
Collapse
|
33
|
Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Van Tieu H, Allen M, Hural J, Graham BS, Kublin J, Gilbert PB, Corey L, Goepfert PA, McElrath MJ, Johnson RP, Huang Y, Frahm N. Antigenic competition in CD4 + T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Sci Transl Med 2020; 11:11/519/eaaw1673. [PMID: 31748227 DOI: 10.1126/scitranslmed.aaw1673] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2018] [Accepted: 10/04/2019] [Indexed: 11/02/2022]
Abstract
T cell responses have been implicated in reduced risk of HIV acquisition in uninfected persons and control of viral replication in HIV-infected individuals. HIV Gag-specific T cells have been predominantly associated with post-infection control, whereas Env antigens are the target for protective antibodies; therefore, inclusion of both antigens is common in HIV vaccine design. However, inclusion of multiple antigens may provoke antigenic competition, reducing the potential effectiveness of the vaccine. HVTN 084 was a randomized, multicenter, double-blind phase 1 trial to investigate whether adding Env to a Gag/Pol vaccine decreases the magnitude or breadth of Gag/Pol-specific T cell responses. Fifty volunteers each received one intramuscular injection of 1 × 1010 particle units (PU) of rAd5 Gag/Pol and EnvA/B/C (3:1:1:1 mixture) or 5 × 109 PU of rAd5 Gag/Pol. CD4+ T cell responses to Gag/Pol measured 4 weeks after vaccination by cytokine expression were significantly higher in the group vaccinated without Env, whereas CD8+ T cell responses did not differ significantly between the two groups. Mapping of individual epitopes revealed greater breadth of the Gag/Pol-specific T cell response in the absence of Env compared to Env coimmunization. Addition of an Env component to a Gag/Pol vaccine led to reduced Gag/Pol CD4+ T cell response rate and magnitude as well as reduced epitope breadth, confirming the presence of antigenic competition. Therefore, T cell-based vaccine strategies should aim at choosing a minimalist set of antigens to reduce interference of individual vaccine components with the induction of the maximally achievable immune response.
Collapse
|
34
|
Ni Choinin A, Allen M, Milewski L, Power D, Connolly R, Collins D, O'Reilly S, Bambury R. 1751P Lessons from a pandemic: An audit of acute medical oncology admissions during SARS-CoV-2 outbreak. Ann Oncol 2020. [PMCID: PMC7506404 DOI: 10.1016/j.annonc.2020.08.1815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
35
|
Battisti N, Lee K, Nash T, Mappouridou S, Senthivel N, Asavisanu K, Obeid M, Tripodaki ES, Angelis V, Fleming E, Goode E, John S, Andres M, Allen M, Lyon A, Ring A. 222P Rates of cardiac adverse events in older versus younger adults receiving trastuzumab for HER2-positive early breast cancer: Results from 931 patients treated at The Royal Marsden. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
36
|
Andrasik MP, Sesay FA, Isaacs A, Oseso L, Allen M. Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials. J Acquir Immune Defic Syndr 2020; 84:488-496. [PMID: 32692107 PMCID: PMC8012001 DOI: 10.1097/qai.0000000000002369] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Given the persistent stigma and discrimination against HIV worldwide, preventive HIV vaccine trials face unique challenges. Negative social impacts (NSIs)-problems that HIV vaccine trial participants face in many different spheres of their lives related to trial participation-have received a great deal of attention. Beneficial social impacts (BSIs)-perceived benefits experienced by a participant and resulting from their trial participation-are a critical component of participants' experiences, yet they have received little attention. SETTING All HIV Vaccine Trials Network trial participants for whom social impact data were available-8347 participants in 13 countries who enrolled in 48 phase 1, 2a, and 2b trials. METHODS A cross-protocol analysis to assess self-reported BSIs and NSIs related to participating in a preventive HIV vaccine trial. Data were obtained from 48 completed HIV Vaccine Trials Network vaccine trials from December 2000 to September 2017. RESULTS Overall, 6572 participants (81%) reported at least one BSI, and 686 participants (8%) reported 819 NSI events. Altruism/feeling good helping others was the BSI most often endorsed by study participants (43%), followed by receiving risk-reduction counseling (30%). Most NSI events (81%) were reported by US/Swiss participants, and most (79%) trial-related NSIs were negative reactions from friends, family, and partners. Of the NSIs reported, 7% were considered to have a major impact on the participant's quality of life. CONCLUSION Our results underscore the relatively common experiences of BSIs among preventive HIV vaccine trial participants and mirror the results of other studies that find infrequent reports of NSIs.
Collapse
|
37
|
Angelopoulos V, Tsai E, Bingley L, Shaffer C, Turner DL, Runov A, Li W, Liu J, Artemyev AV, Zhang XJ, Strangeway RJ, Wirz RE, Shprits YY, Sergeev VA, Caron RP, Chung M, Cruce P, Greer W, Grimes E, Hector K, Lawson MJ, Leneman D, Masongsong EV, Russell CL, Wilkins C, Hinkley D, Blake JB, Adair N, Allen M, Anderson M, Arreola-Zamora M, Artinger J, Asher J, Branchevsky D, Capitelli MR, Castro R, Chao G, Chung N, Cliffe M, Colton K, Costello C, Depe D, Domae BW, Eldin S, Fitzgibbon L, Flemming A, Fox I, Frederick DM, Gilbert A, Gildemeister A, Gonzalez A, Hesford B, Jha S, Kang N, King J, Krieger R, Lian K, Mao J, McKinney E, Miller JP, Norris A, Nuesca M, Palla A, Park ESY, Pedersen CE, Qu Z, Rozario R, Rye E, Seaton R, Subramanian A, Sundin SR, Tan A, Turner W, Villegas AJ, Wasden M, Wing G, Wong C, Xie E, Yamamoto S, Yap R, Zarifian A, Zhang GY. The ELFIN Mission. SPACE SCIENCE REVIEWS 2020; 216:103. [PMID: 32831412 PMCID: PMC7413588 DOI: 10.1007/s11214-020-00721-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Accepted: 07/09/2020] [Indexed: 06/11/2023]
Abstract
The Electron Loss and Fields Investigation with a Spatio-Temporal Ambiguity-Resolving option (ELFIN-STAR, or heretoforth simply: ELFIN) mission comprises two identical 3-Unit (3U) CubeSats on a polar (∼93∘ inclination), nearly circular, low-Earth (∼450 km altitude) orbit. Launched on September 15, 2018, ELFIN is expected to have a >2.5 year lifetime. Its primary science objective is to resolve the mechanism of storm-time relativistic electron precipitation, for which electromagnetic ion cyclotron (EMIC) waves are a prime candidate. From its ionospheric vantage point, ELFIN uses its unique pitch-angle-resolving capability to determine whether measured relativistic electron pitch-angle and energy spectra within the loss cone bear the characteristic signatures of scattering by EMIC waves or whether such scattering may be due to other processes. Pairing identical ELFIN satellites with slowly-variable along-track separation allows disambiguation of spatial and temporal evolution of the precipitation over minutes-to-tens-of-minutes timescales, faster than the orbit period of a single low-altitude satellite (Torbit ∼ 90 min). Each satellite carries an energetic particle detector for electrons (EPDE) that measures 50 keV to 5 MeV electrons with Δ E/E < 40% and a fluxgate magnetometer (FGM) on a ∼72 cm boom that measures magnetic field waves (e.g., EMIC waves) in the range from DC to 5 Hz Nyquist (nominally) with <0.3 nT/sqrt(Hz) noise at 1 Hz. The spinning satellites (Tspin ∼ 3 s) are equipped with magnetorquers (air coils) that permit spin-up or -down and reorientation maneuvers. Using those, the spin axis is placed normal to the orbit plane (nominally), allowing full pitch-angle resolution twice per spin. An energetic particle detector for ions (EPDI) measures 250 keV - 5 MeV ions, addressing secondary science. Funded initially by CalSpace and the University Nanosat Program, ELFIN was selected for flight with joint support from NSF and NASA between 2014 and 2018 and launched by the ELaNa XVIII program on a Delta II rocket (with IceSatII as the primary). Mission operations are currently funded by NASA. Working under experienced UCLA mentors, with advice from The Aerospace Corporation and NASA personnel, more than 250 undergraduates have matured the ELFIN implementation strategy; developed the instruments, satellite, and ground systems and operate the two satellites. ELFIN's already high potential for cutting-edge science return is compounded by concurrent equatorial Heliophysics missions (THEMIS, Arase, Van Allen Probes, MMS) and ground stations. ELFIN's integrated data analysis approach, rapid dissemination strategies via the SPace Environment Data Analysis System (SPEDAS), and data coordination with the Heliophysics/Geospace System Observatory (H/GSO) optimize science yield, enabling the widest community benefits. Several storm-time events have already been captured and are presented herein to demonstrate ELFIN's data analysis methods and potential. These form the basis of on-going studies to resolve the primary mission science objective. Broad energy precipitation events, precipitation bands, and microbursts, clearly seen both at dawn and dusk, extend from tens of keV to >1 MeV. This broad energy range of precipitation indicates that multiple waves are providing scattering concurrently. Many observed events show significant backscattered fluxes, which in the past were hard to resolve by equatorial spacecraft or non-pitch-angle-resolving ionospheric missions. These observations suggest that the ionosphere plays a significant role in modifying magnetospheric electron fluxes and wave-particle interactions. Routine data captures starting in February 2020 and lasting for at least another year, approximately the remainder of the mission lifetime, are expected to provide a very rich dataset to address questions even beyond the primary mission science objective.
Collapse
|
38
|
Curlin ME, Shao J, Diaz G, Edlefsen PT, Novak RM, Mayer KH, Allen M, Morgan C, Maenza J, Buchbinder S, Keefer MC, Rosa SCD, Corey L, Duerr A. Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine. Vaccine 2020; 38:5814-5821. [PMID: 32680773 DOI: 10.1016/j.vaccine.2020.06.043] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Revised: 06/06/2020] [Accepted: 06/16/2020] [Indexed: 12/16/2022]
Abstract
BACKGROUND Vaccine-induced mucosal immune responses may be critical for protection against HIV infection, but may also result in short or long-term changes that enhance susceptibility to infection in some individuals, such as those with baseline seroreactivity to vaccine vector antigens. We examined cellular immune responses in blood and gut mucosal tissue roughly two years following vaccination with placebo or the Step study vaccine MRKAd5/HIV-1. METHODS Participants vaccinated with either placebo or MRKAd5/HIV-1 during participation in HVTN 071, and HVTN 502/Merck 023 underwent phlebotomy and colonic mucosal biopsies via flexible sigmoidoscopy at two timepoints roughly six months apart. After isolation of mononuclear cells, we compared cellular phenotypes and intracellular cytokine responses in vaccine and placebo recipients with and without baseline serological reactivity to Ad5. RESULTS Surface expression of activation and gut-homing markers were elevated on CD4 + and CD8 + gut mucosal mononuclear cells (GMMC) in comparison with PBMC (p < 0.01), but were not significantly affected by baseline Ad5 serostatus or receipt of MRKAd5/HIV-1. ICS responses to stimulation with vaccine antigens were of low frequency and magnitude. Ad5 vector responses were seen in vaccinees and baseline seropositive individuals. CD4 + responses to vector antigens were more common in GMMC than PBMC (p < 0.01) and CD8 + responses to HIV gag insert antigens were more frequent in Ad5 seropositive than Ad5 seronegative individuals (p = 0.03). CONCLUSION Vaccination with the Ad5 vectored candidate HIV vaccine MRKAd5/HIV-1 does not lead to long-term changes in the activation state of mucosal CD4 + or CD8 + T lymphocytes regardless of baseline Ad5 serostatus. The findings of this study do not reveal a basis for enhanced susceptibility to HIV infection two years post vaccination.
Collapse
|
39
|
Baldwin F, Gray R, Boyd O, Waxman D, Patel B, Allen M, Scutt G. Safe prognostication following cardiac arrest: The role of the pharmacokinetics of fentanyl in patients treated with targeted temperature management. Resuscitation 2020; 149:10-16. [DOI: 10.1016/j.resuscitation.2020.01.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Revised: 01/23/2020] [Accepted: 01/26/2020] [Indexed: 11/25/2022]
|
40
|
Chapman SJ, Blanco-Colino R, Pérez-Ajates S, Bautista OA, Hodson J, Blanco-Colino R, Chapman SJ, Glasbey JC, Pata F, Pellino G, Soares ASA, van Elst T, Van Straten S, Nepogodiev D, Hodson J, Borakati A, Bath MF, Yasin IH, Mclean K, Arthur T, Kovacevic M, Delibegovic S, Karamanliev M, Swamad M, Žebrák R, Paramasivam R, Martensen A, Larsen HM, Rãdeker L, Frey PE, Kechagias A, Venara A, Duchalais E, Ioannidis A, Pata F, Pellino G, Pasquali S, Simioni ASA, Farina V, Podda M, Lorenzon L, ItSURG, Schaeff V, Otto A, Jakubauskas M, van Elst TR, Chu M, Fagan PVB, Wells CI, João AA, Soares A, Juloski J, Blanco-Colino R, Pérez-Ajates S, Bautista OA, El Kasmi YEK, Espin-Basany E, Clerc D, Ciubotaru C, Popescu S, Yanishev A, Lee S, Ozkan BB, Sen AY, Aktas MK, Baki BE, Yüksek B, Glasbey JC, Kamarajah S, Mclean K, Borakati A, Yasin IH, Khaw RA, Mills E, Goodson R, Thakral N, Ablett AD, Adra M, Kwek I, Khan SM, Quinn P, Manley LR, Badran A, Ramjeeawon A, Campbell A, Tan HL, Rye DS, Rajaraman N, Norman JG, Vutipongsatorn K, Solomou G, Akhbari M, Ali A, Brandao BD, Stainer B, Thavayogan R, Jones D, Onafowokan OO, Gharooni A, Dabab N, Carlton-Carew S, Kungwengwe G, Gabriel M, Sewart E, Shortland TC, Lawday S, Pockney P, Dawson A, Stewart P, Ng B, Luong JK, Delibegovic S, Ivanov V, Borisova A, Neykov V, Žebrák MFR, Harbjerg JL, Brandsborg S, Mark-Christensen A, Unbehaun KP, Dalsgaard P, Lycke KD, Kechagias A, LeNaoures P, Duchalais E, Brigand C, Dumange E, Gout M, Moehwald C, Prem M, Alhalabi O, Sliwinski S, Krupp J, Gablenz E, Schmitzer L, Kopp A, Steinle J, Gsenger J, Pohl LJ, Riccardi M, Christodoulou IM, Konstantinidis M, Machairas N, Zoikas A, Balalis D, Manatakis DK, Aguilera ML, Simioni ASA, Marano L, Fleres F, Lovisetto F, Sasia D, Segalini E, Pata G, Lucchi A, Sagnotta A, Campagnaro T, Petrelli F, Gallo G, Papandrea M, Testa V, Sinibaldi G, Di Candido F, Colombo F, Perrone G, Aresu S, Biancafarina A, Canonico G, Pagnanelli M, Curletti G, Bini R, de Manzoni Garberini A, Impellizzeri H, Cillara N, Tutino R, Picciariello A, Coletta D, Savino G, Ferrara F, Tamini N, Talamo G, Parini D, Giamundo P, Pagano G, Ripetti V, Pesce A, Menduni N, Pellino G, Giudicissi R, Podda M, Goldin E, Rega D, Belli A, Andriola V, Gordini L, Pata F, Foppa C, Piccolo G, Birindelli A, Ferrari C, Ballarini Z, Tirelli F, Milone M, De Rosa M, Federico NSP, Molteni B, Tilocca PL, Sancini G, Piozzi GN, Lauretta A, Mulas S, Schaeff V, Otto A, Jakubauskas M, Simcikas D, Portelli L, van Wijnbergen JWM, Dinger TL, ten Doesschate SFH, van Dalen ASHM, van den Bos DD, Hansmann M, Feliz JM, Kuiper SZ, Abdulrahman Z, Pruijssers SR, Geneta VP, Chu M, Wilton S, Kandelaki H, Peng SL, Campbell S, Lim YK, Yassaie SS, Murray M, Fagan PVB, Haran C, Tan J, Castro J, Laranjeira A, Catarino S, Neves-Marques C, Correia JG, Vieira BN, Quintela AC, Serra ML, Maciel J, Cunha M, Aparício DJ, Neves J, Azevedo J, Romano M, Eiró F, Romano J, Monteiro C, Claro M, Almeida, Peyroteo M, Machado ND, Capote H, Ferreira M, Sousa X, Devesa H, Cavadas D, Guerreiro I, Costa M, Rosete M, Salman M, English C, Mohammed N, Popescu S, Yanishev A, Litvin A, Ćuk VV, Mészárosová K, Van Straten S, Jaich R, De Lima H, Brooks S, Marx M, Salvation MN, Cardo JG, Mora-Guzmán I, Muriel JS, de Andres Olabarria U, Muriel P, Viñas CJ, Alconchel F, Sinovas OE, El Kasmi YEK, Oro CF, Pérez-Ajates S, Otero ML, Jiménez SF, Bellmunt OC, Caballero JM, Rubio-Pérez I, Aguilar-Martínez MM, Segura-Sampedro JJ, Moreno CO, Parra DN, Diz AME, Martín-Balbuena R, Recuenco CB, Bolaños REL, Fernández P, Padillo AD, Forero-Torres A, Román IAS, Rosés HS, Campos PV, Moreira CCL, Peralta PU, Navidad MS, Ripollés-Melchor J, Garcea A, Facundo HG, Bautista OA, Pereira PT, Guarinos CVP, Clerc D, Blaser B, Piazza G, Gagliardi B, Serin H, Sen AY, Yurdaor SS, Aktas MK, Arslan E, Kopac O, Uyanik A, Ozmen BB, Tiftik E, Aksoy B, Yalcinkaya A, Bilicen G, Cinar EN, Uslu Ö, Kaya Y, Wong J, Farhan-Alanie MMH, Suresh G, Asif A, Finch BJ, Bhahirathan Y, Herron J, Tew ZY, Obukofe R, Russell C, Suchett-Kay I, Netke T, Williams L, Kisiel A, Liu FY, Claireaux H, James P, Mondal A, Kalderon R, Nadama HH, Al-Saraff Z, Tam JPH, Powell-Chandler A, Wood F, Campbell A, Gorgievska R, Ragavoodoo A, Thakrar C, Rojoa D, Palmer C, Davidson K, Giacci L, Hale J, Gan FW, Makin-Taylor R, Hey CY, Toh C, Findlay JM, Griffiths N, Ganesananthan S, Jasionowska S, Poustie M, Wong C, Turner T, Pyc W, Sloper W, Warner C, Coey J, Mason D, Sait S, Kowal M, Shortland TC, Owen M, Saiyed A, Ashworth I, Akbari K, Curran M, Martin P, Parker D, Dawson A, Kwok K, Lye C, Pockney P, Ghaly M, Sammour T, Lewis D, Mundasad R, Wilkes A, Ctercteko G, Stewart P, Delibegovic S, Maslyankov S, Dimov R, Iliev S, Dimitrov D, Marek F, Örhalmi J, Skalický P, Skalický T, Chrz K, Christensen P, Worsøe J, Kristensen ES, Emmertsen KJ, Loeve US, Duchalais E, Mihaljevic AL, Herrle F, Konstantinidis KM, Manatakis DK, Korkolis D, Karanikas I, Aguilera ML, Vincenti L, Anania G, Borghi F, Agresta F, Maretto I, Parisi A, Bucci L, De Palma G, Guglielmi A, Cucinotta E, La Torre F, Cianchi F, Guerrieri M, Lauretta A, Trompetto M, Persiani R, Micheletto G, Delrio P, Belli A, Cantafio S, Lovisetto F, Ronconi M, Bisagni PAG, De Prizio M, Tamini N, Sinibaldi G, Franceschi A, Galleano R, Cavallini M, Brescia A, D'Ambra L, Benevento A, Niolu P, Calgaro M, Colangelo E, Grottola T, Altomare DF, Puleo S, Salamone G, Pietrabissa A, Poggioli G, Ripetti V, Erdas E, Ottonello R, Canonico G, Tonini V, Selvaggi F, Sammarco G, Ceccarelli G, De Nisco C, Surgo D, Taglietti L, Ozolins A, Sivinš A, Poskus T, Psaila J, Bemelman WA, Graat LJ, Langenhoff B, Wijnhoven BPL, van de Ven AHW, Poelman M, Stassen LPS, Slooter G, Acherman YIZ, Hoff C, Gerhards MF, Stommel MWJ, Hazebroek EJ, van Geloven AAW, Schasfoort RA, van Leeuwen BL, Tuynman JB, van Tilburg MWA, Boerma EG, Sharma P, Jenkins B, Bissett IP, Peng SL, Herd A, Gordon A, Vernon D, Omundsen M, Ly J, Reddy A, Bonnet G, Harmston C, Morales M, Francisco V, Costa S, Manso A, Amorim E, Pereira J, Cardoso J, Ourô S, Caratão M, Nascimento C, da Silva BR, Taranu V, Dias R, Devesa H, Mendes J, Allen M, Silva A, Carlos S, Barbosa E, Carneiro C, Ramos L, Maciel J, Lencastre L, Martins R, Silva-Vaz P, Cahill R, Hogan A, Larkin J, Negoi I, Abelevich A, Ćuk VM, Vician M, Ede C, Sardiwalla I, Mulira S, Montwedi D, Oyomno M, Sabia D, Porras VP, Vigorita V, Ortega GS, García J, Macías AE, Antona FB, Mompeán JAL, Ruiz SS, Villarejo-Campos P, Simó MR, Sánchez-Guillén L, Jiménez-Gómez LM, López AS, Golda T, Bergkvist DJ, Nevado C, Aguilar JFN, Felipe BR, Septiem J, Sánchez AR, Cañete-Gómez J, Montesinos IR, Ripollés-Melchor J, Millán-Scheiding M, Prieto-Nieto I, Segura-Sampedro JJ, Espin-Basany E, Frasson M, Román IAS, Olmo DG, Hübner M, Petermann D, Sauvain MO, Ozben V, Geçim IE, Disçi E, Rencuzogullari A, Kurt A, Bisgin T, Pehlivan M, Isik A, Onur E, Leventoglu S, Keskin M, Guner A, Sahin ST, Ozbalci GS, Pergel A, Albayrak D, Bruce D, Fearnhead N, Arthur J, Harron M, Beattie G, Titu L, Ali A, Saunders M, Phillips J, Dindyal S, Cresswell B, Gercek Y, Lee J, Linn T, Faulkner G, Lockwood S, Rees J, Charalabopoulos A, Campbell B, Kontovounisios C, Amarnath T, Johnson M, Epanomeritakis E, Vigs S, Nastro P, Gilliam A, Smolarek S, Wilson T, Orbell J, McIntyre R, Agarwal T, Hainsworth P, Patel P, Vijay J, Liu B, Rao PD, Roxburgh C, Vipond M, Youssef H, Thorn C, Schizas A, Denley S, Bowley D, Das K, Cuming T, Saha A, Chung L, Pitt J, Davis P, Jones O, Taylor M, Bhargava A, Haji A, Watson N, Bloom I, Singh B, Norwood M, Gurjar S, Stylianides N, Mirza S, Evans M, Williams G, Patil P, Hernon J, Finch G, Green S, Chapple K, Fafemi O, Warusavitarne J, Samee A, Carden C, Ong L, Verma K, Joseph A, Rawat N, Pinkney T, Oke O, Glen P, Maxwell-Armstrong C, Oliphant R, Garner J, Moug SJ, Middleton S, Lund JN, Smart NJ, Osborn G, Moore T, Raymond T, Knowles CH, Hany TS, Clarke R, Khera G, Brady R, Sellahewa C, Mason C, Torrance A, Lasithiotakis K, Knight J, Pullybank A, Ainsworth P, Reid F, Ramwell A, Maslekar S, George R, Skull A, Holtham S, Muhammad K, Lal R, Varcada M, Smith FM, Howlader M, Defriend D, Kirk S, Richards T, Evans C, Borg CM, Telford K, Sarfraz N, Busby K, Hollingshead J, Speake D, Pawa N, West D, Chadwick M, Komolafe O, Richardson S, Thornton M, Goede A, Osborne C, Bandyopadhyay D, Foong J, Lee YJ, Liebenberg P, Mijalkov D, Wells A, Bull N, Ajmera A, Warburton T, Morgan S, Mahmoud A, Schachtel M, Mikhail B, Fomin I, Mekaeil B, Taylor N, Stevenson C, Drane A, Pahalawatta U, Lai LT, Debiasio A, Chrimes A, Agarwal A, Zhao J, Williams S, Jayalath JMSN, Liebenberg P, Khor S, Muddasani T, Childs S, Ridgway S, Blefari NDA, Tam H, Puchalski N, Ngai C, Horne D, Borrow JL, Campbell C, Cousins G, Jackson L, Maheepala K, Zhao S, Holden E, Tutt L, Thompson B, Collins H, Louie F, Buckland B, Smith D, Chong C, Chua TH, Nayak C, Redmond J, Tan RR, Gramlick M, Teh JS, Ng SY, Britten-Jones P, Rosli RM, Pham HDV, Jegathees T, Coulter-Nile SMCJ, Gosselink MP, Luong JK, Wang YL, Maciaszek M, Chrapko PS, Nair A, Thirugnanasundralingam V, Muir K, Salibasic M, Pavlov V, Paycheva T, Borisova A, Lyulenina E, Kolev N, Ivanov V, Nguen D, Mitkov Y, Mitkov E, Vladova P, Dimitrov V, Hussain M, Gabarski A, Ivanov T, Yotsov T, Ilieva I, Karamanliev M, Akisheva A, Shoshkova M, Nawaz E, Feradova H, Mladenov T, Neykov V, Jozaf V, Klail MFT, Pös M, Adel A, Sotona O, Bartoš M, Amjad T, Malý O, Berec S, Hurný MHM, Chodora S, Houdek O, Novický R, Antonova T, Cha KSS, Kimle KŠ, Jirankova K, Bujda M, Paclík A, Trap A, Jürgens-Lahnstein J, Storm M, Dalsgaard P, Damgaard I, Olawi F, Ehlern F, Raos M, Kristensen FP, Lycke KD, Bønnerup K, Unbehaun KP, Brandsborg S, Amiri S, Enevoldsen M, Harbjerg JL, Pedersen JH, Jepsen BN, Hillgaard TK, Erichsen SB, Nielsen CV, Madsen CP, Bjerke J, Skejø CD, Aabling RR, Sørensen JS, Mark-Christensen A, Kechagias A, Turunen A, Katunin J, Niskakangas M, Vignaud T, Frey S, Ricolleau C, Chanut F, Magnin J, Gout M, Seiboldt T, Beck L, Pohl LJ, Zamzow K, Betge F, Poncelet A, Truant M, Hauschild H, Neugebauer N, Schöning L, Simon SCS, Galata C, Karampinis I, Thãwel T, Seckler AM, Kerem C, Durdevic S, Ioannidis A, Antonakopoulos F, Konstantinidis M, Mathioulaki A, Chrysoheris P, Athanasopoulos PG, Kalles V, Spyrou I, Barkolias C, Paspala A, Machairas N, Papaconstantinou D, Spartalis E, Arkadopoulos N, Prodromidou A, Garoufalia Z, Balalis D, Zoikas A, Christodoulou IM, Mendez D, Rosales J, Flores M, Garcia M, Garcia A, Garcia M, Noriega Z, Torselli D, Aguilera ML, Rodriguez J, Lafranceschina S, Artioli E, Giaccari S, Nevoso V, Schimera A, Marino S, Geretto P, Pellegrino L, Borghi B, Sasia D, Marano A, Corino C, Cannata G, Giuffrida MC, Landra F, Pata G, Ongaro D, Baronio G, Raimondo S, Casiraghi S, Salvadori R, Savino G, Finotti E, Ciccioli E, Galgano A, Zuin M, Simioni A, Bettella A, Barina A, Vendramin E, Palano G, Schiavone D, Di Cintio A, Gemini A, Trastulli S, De Luca M, Sagnotta A, Desiderio J, Gubbiotti F, Cigognini M, Zaffaroni G, Maffioli A, Colombo S, Bondurri A, Sampietro G, Foschi D, Colombo F, Manigrasso M, Danzi M, Amato R, Anastasio L, Mastella F, Basile R, Peltrini R, Marra E, Luglio G, Pagano G, Giglio M, Manigrasso M, Anoldo P, Vertaldi S, Grimaldi L, Tammaro N, Pedrazzani C, Campagnaro T, Turri G, Lazzarini E, Conti C, Vulcano I, Bertilone E, Pintabona G, Viscosi F, Cerasari S, Galiffa G, Lapolla P, Coletta D, Del Basso C, Cirillo B, De Toma G, Fazzi K, Bini S, Coratti F, Montanelli P, Grandi S, Nelli T, Khaled NB, Tilocca PL, Marrosu AG, Scognamillo F, Pala C, Attene F, Carboni L, Ruggiu MW, Gabbas G, Marziali I, Mazzocato S, Petrelli F, Vergari R, Piazzai F, Kubolli I, Aggiusti A, Paolucci A, Ortenzi M, Olivieri M, Belluco C, Antona AD, Basso S, Morino M, Mistrangelo M, Testa V, Gallo G, Clerico G, De Santi G, Bitonti MF, Trompetto M, Federico NSP, Frattalone M, Tirelli F, Fico V, Santullo F, Belia F, Spinelli A, Marco M, Di Candido F, Bevilacqua M, Tringali D, Bevilacqua E, Panizzo V, Piozzi GN, La Manna V, Migliore G, Aversano A, Bucci AF, Marino F, Carbone F, Incollingo P, Romano FM, Giudicissi R, Zalla T, Baraghini M, Romoli L, Calussi M, Vellei S, Genzano C, Feroci F, Vita M, Barberis A, Serra D, Lucchi A, Grassia M, Romelli M, Ruggiero S, Percassi A, Ferrari C, Molteni B, Piccinini AM, Segalini E, Monti M, Magnoli M, Romano S, Gaetano P, Pilotta F, Baldassarre L, Perrone G, Bonati E, Aresu S, Saba A, Moretto G, Bacchion M, Impellizzeri H, Casaril A, Inama M, Creciun M, Ferrara F, Stella M, Gobatti D, Biancafarina A, Angelini M, Andolfi E, Miranda E, Scricciolo M, Provenza G, Cavallina G, Frezza B, Fontani A, Malatesti R, Pellicanò GA, Podda M, Anania M, Pulighe F, Cruccu A, Murru ML, Massaiu C, Balestra F, Pazzona M, De Nisco C, Giannella A, Santangelo M, Olivieri M, Frangella F, Magagnano D, Liberatore P, Brenna R, Giani A, Tirotta F, Famularo S, Angrisani M, Ceresoli M, De Rosa M, Rondelli F, Ceccarelli G, Angelucci GP, Scaramuzzo R, Larcinese A, Fioriti C, Picone E, Nardi M, Marano L, Castagnoli G, Bartoli A, Bellochi R, Spaziani A, Conti D, Poponesi V, Trippetti M, Amicucci S, Tazza G, Procacci P, Giovannini F, Basile E, Franceschi A, Caristo G, Pagnanelli M, De Nardi P, Rosati R, Marcocci G, Vignali A, Curletti G, Galleano R, Badran A, Malerba M, Percivale A, Ghazouani O, Reggiani L, Spirito C, Moschetta G, Cosmi F, Romeo G, Gasparrini M, Sucameli F, Gennai A, Moggia E, Bianchi C, Bonfante P, Macina S, Feleppa C, Talamo G, Imperatore M, Tenconi SM, Rausei S, Maioli D, Marchionini V, Pata F, Sparta C, De Angelis M, Mereu A, Adamo V, Bianco C, de Manzoni Garberini A, Ricciardiello M, Campanaro C, Panaccio P, Esposito LM, D'Ascanio F, Pietroletti R, Picciariello A, Chetta N, Aquilino F, Di Marco F, Amico A, Schembari E, Puglisi S, Licari L, Campanella S, Profita G, Falco N, Rotolo G, Venturelli P, Tutino R, De Marco P, Marcianò M, Argenti ASF, Sancini G, Roggiani A, Balsamo F, Gori A, Cuicchi D, D'Alessio R, Benvenuto D, Gordini L, Erdas E, Podda F, Cappellacci F, Salaris C, Sanna S, Marcialis J, Mosino L, Peddis M, Melis S, De Donno G, Aru AC, Falsetti E, Parini D, Lanari J, D'Errico U, Bianchini S, Birindelli A, Figà F, Caiazzo A, Selvaggi L, Capozzolo A, Cerra C, Pirillo M, Papandrea M, Cravano S, Libri I, Laquatra N, Isabello A, Truškovs A, Bartnick A, Malcevs E, Machatschek MJ, Alm J, Lapsa S, Delorme M, Zeynalov F, Larnovskis J, Sauka J, Bodrov D, Gailumsis R, Wiemann AM, Müller NL, Jelovskis I, Deksnis D, Potts OB, Slimbajevs T, Samalavicius NE, Simcikas D, Nutautiene V, Zeromskas P, Jurgaitis J, Aliosin O, Slepavicius A, Eismontas V, Kybransiene M, Dulskas A, Kuliavas J, Kavaliauskas P, Kavaliauskaite R, Poškus E, Danys D, Kryžauskas M, Mikalauskas S, Rackauskas R, Drungilas M, Poškus T, Jotautas V, Strupas K, Cachia C, Cefai C, Portelli L, Youssef Y, Degaetano D, Debono S, Sammut M, Cassar J, Sammut K, Looijen RC, van Dalen ASHM, Becker J, Comert D, te Molder L, Tromp J, Matthee E, Tissen YM, Kakar S, ten Doesschate SFH, van Smaalen TC, Veen OC, Dingemans SA, van den Brink LC, Vijgen GHEJ, van de Voort EMF, van der Pool A, van Rest KLC, Haak T, Sluijpers NRF, Pruijssers SR, Molenaar CJL, de Gouberville MCG, Saleh S, Mens MA, Hoeks EM, Nieuwenhuizen S, van Praag EM, Westerduin E, Smit MPCM, van der Lely SJ, Nasimi B, Gerdsen M, Stijns RCH, Leow TYS, Penningnieuwland G, Alqethami HJ, Constansia R, van Elst PC, Tissink MW, Grüter A, Vroom Y, Azzahhafi J, Bofarid S, Kip M, Saleh W, Franssen S, Boon CL, Franssen RJM, Romaen I, Jense MTF, D'Souza J, Pascoe R, Scott A, Stark E, Mulholland K, Lau WK, Smith B, Adams SIB, Shah N, Ling E, Young J, Peng SL, Jacobson A, Macfater H, Farik S, Chen SY, Kilpatrick K, Kim DH, Dixon S, Yassaie S, Welman D, Coulter J, Morreau M, Li E, Rankin A, Winders J, Skipworth C, Fagan PVB, Stanfield B, Henderson N, Chuang A, Maskill L, Ker H, McLaughlin SJP, Kearney J, Wilton S, Sprosen H, Kerckhoffs P, Koh S, Wilms H, Dalzell F, Tewhaiti-Smith J, Kader T, Yam ST, Dahya D, Boys MH, Fleischl W, Tan J, Skavysh A, Mouldey K, Guerreiro I, Patrocinio MTS, Amado F, Batista A, Seabra J, Praxedes V, Monteiro N, Martins I, Serra ML, Santos TC, Lages RR, Pimentel A, Machado ND, Bernardes TCSFM, Saraiva P, Almeida J, Mendes M, Fernandes V, Ribeiro A, Soares D, Costa M, Martins T, Miguel I, Martins J, Cunha MF, Melo J, Veiga DN, Rachadell J, Rachadell J, Amorim E, Vareda R, Roseira J, Catarino S, Aveiro D, Couto M, Loureiro AR, Louro H, Queiros T, Castro B, Fonseca S, Carvalho L, Torre AP, Amado A, Leite M, Miranda P, Cunha C, Ferreira M, Cavadas D, Silva R, Pina S, Paixão I, Orelhas L, Santos J, Pacheco A, Rocha AF, Jervis MJ, Pedro V, Paixão V, Guerreiro A, Melo D, Correia D, Capella V, Moinhos T, Monteiro C, Silva M, Vieira BN, Silva AG, Galvão D, Mora A, Bettencourt R, Costa F, Gil I, Morgado J, Neves J, Mónica I, Oliveira S, Ribeiro H, Ferreira M, Guimarães N, Duarte M, Miranda J, Martins SF, Faustino A, Medeiros N, Castro R, Soares B, Resendes M, Almeida P, Cruz A, Claro M, Fialho G, Reia M, Pratas N, Capote H, Costa C, Costa J, Morais S, Machado A, Horta V, Rocha-Melo M, Patrício J, Pereira M, Lima R, Cinza AM, Oliveira J, Velez C, Ferreira M, Borges F, Simões J, Eiró F, Botelho P, Cismasiu B, Alves D, Dias B, Costa C, Gonçalves JP, Valente P, Oliveira J, Freire L, Saraiva R, Moreira M, Fragoso M, Guimarães J, Cruz G, Aparício DJ, Ribeiro J, da Ponte IB, Almeida S, Martins AR, Louro T, Morgado M, Ferreira AS, Alves M, Oliveira N, Lérias R, Neves-Marques C, Estalagem I, Botelho C, Bártolo J, Antunes CF, Cabral F, Silva FB, Matos AD, Santos M, Cunha R, Duarte M, Sousa M, Canotilho R, Peyroteo M, Correia AM, Martins PC, Jardim JAM, Domingos SP, Baião JM, Romano M, Gomes JR, Monteiro RG, Varghese S, Boyle E, Aljohmani L, Alexander J, Graziadei V, McCaughey C, Jain A, Lee J, Ramanayake H, Sabnani R, Colon LF, Bansal N, Stephens I, Tan R, Sharma S, Doherty G, Fenn S, Mulhare E, Walsh M, Leavey C, Costigan O, Dervan L, Kang SJ, Dixon O, Morrissey E, Compton M, Pentony AR, Piong CL, Nossier R, Hanna J, Sabir K, Eow SY, Ladak N, Boersma D, Kamath PJ, Soh TBW, Dyer AH, Chee SY, Tan IXH, Kelliher A, Adeusi L, Howarth N, McCawley N, O'Neill A, Jones MR, Saleh R, Singh A, Senaratne R, Kakodkar P, Subramanian I, Hogan A, Al-Salihi A, Vyas V, Vedadi A, Popescu SS, Piras K, Ciubotaru CI, Litvin A, Romanova E, Ponomarev N, Savchenko A, Yanishev A, Luzan R, Lutovinova E, Gavrilina A, Barkovskaya A, Kudelkina N, Topchubaev D, Radulović R, Miloševic K, Ćuk VV, Bojičić J, Juloski J, Genčić M, Janković U, Zubowicz M, Sucháň PK, Gerstmeier J, Brazitikou KME, Fytrou E, Celik M, Dubovský M, Schmalenbeck J, Sautter SC, Ceyran H, Jaich R, Fitchat N, Mathebula S, Chauke J, Mculu W, Ngwenya Z, Withey K, Piperidis A, Toyi Y, Nicolaides A, Jaffer T, Sparke A, Van Staden N, McDuling CR, Claassen L, Kruger C, Weyers J, Marx M, Lecler J, Yebes A, Bautista OA, Mana OC, Gomez H, Riba L, Perez J, Cornejo LC, Rodríguez IV, Escovar FJ, de Andres Olabarria U, Fernández MC, Martínez AP, Bergara IB, Olavarria AL, del Pozo Andrés E, Yebes A, Ortega C, Arias-Camisón PL, Jiménez SF, Arranz JMN, Sexmero MJM, Alonso ED, Oro CF, Moreno AI, Margarida A, Pando B, Marín LL, Calle MP, Cordero MJR, Cuartango AS, Sánchez E, Rodrigo AM, Diago JP, Lista MV, Terricabras SR, Sanz LB, Camprubí EA, Ferrández MR, Lao EP, Miró MDP, Alberca-Paramo A, Verdejo TA, Cañete-Manzanares J, Molina-Florez M, Hernández LCG, Nuñez SO, Suarez-Sanchez M, Martin-Fernandez J, Liébana MMS, Parra DN, Betancourth CFC, Mico SS, Fernandez A, Curtis C, Bosch M, Triguero D, Ramírez MB, Díaz NR, Caraballo IG, Vicente TP, Orue-Echebarria MI, Sánchez-Calvo L, Wang D, Trueba-Collado C, de Quirós JTMB, Peralta PU, Jiménez FAR, Román IAS, Ortega AP, Barbadillo AT, Pujana ER, Illera MVF, Bellmunt OC, Serralvo ADLL, Muriel P, Mestres N, Cuello E, Merichal M, Sierra JE, Escoll J, Rufas M, Pinillos AI, Ortega J, Navidad MS, Angeles PV, Figueras RV, Sanfeliu EB, Alonso BC, Prats MA, Arrocha JD, Garceso NC, Galeano CU, Rodríguez P, Orozco JJG, Alvarez MM, Batanero EA, Canales IC, Calzada MG, Recuenco CB, Martin MC, Avendaño IE, Relimpio CJ, Lavilla PL, Andrés CB, Forero-Torres A, Alonso-Poza A, Dieguez B, Losada M, Gilsanz C, Moreno CO, Idoate CP, Abad-Motos A, Marínez-Hurtado E, Salvachua-Fernández R, Zegarra EDP, Franco M, Martinez A, Martin PR, Mate PM, Chavez CM, Rubio-Perez I, Ayllon H, Jerí-McFarlane S, Soldevila-Verdeguer C, Pineño-Flores C, Ambrona-Zafra D, Fernández-Vega L, Gil-Catalán A, Craus-Miguel A, Pujol-Cano N, Sena-Ruiz F, Jurado MJG, Delgado PA, Reverter AB, del Pulgar AG, El Kasmi YEK, Belzunce-Capó JF, Tremolosa MV, Lin Q, Muniesa C, Avelino L, Cholewa H, Sancho-Muriel J, Navasquillo M, Navío A, Abelló D, De Jesus M, Alvarez E, Pereira PT, Garcia JM, Gil A, Giordano HE, Mignon G, Vanoni A, Henkens A, Jarrar G, Odovic M, Willemin M, Milliet O, Hahnloser D, Clerc D, Demartines N, Piazza G, Teixeira H, Pittet O, Haller ML, Gagliardi B, Huot A, Blaser B, Kefleyesus A, Bugmann A, Piotet LM, Meijers L, Kurtoglu GK, Sel EK, Isler VC, Güner B, İşlek EC, Tombul HB, Boztuğ CY, Tınaz A, Yılmaz M, Karaman Y, Akın FA, Dansuk S, Başçavuş M, Kaya M, Kutlu B, Seker MC, Erten V, Memis U, Koçak ZB, Karapinar YE, Fakirullahoglu M, Uslu Ö, Köseoglu E, Yeni M, Aktas MK, Aykun N, Agca MH, Bilen C, Kilinc I, Atar C, Kilic V, Aktuna C, Aba M, Alim YE, Binbuga M, Kürklü Ö, Yurdaor SS, Ceylan C, Yilmaz S, Çalar SN, Yildirim N, Yavuz G, Sen AY, Can B, Cesmeli E, Kus D, Kavar RC, Cevlik AD, Cengiz U, Turk EG, Yilmaz I, Yüksek B, Erdönmez H, Gürsoy F, Serin H, Kara H, Önsal U, Özbek M, Kasar PA, Ipor A, Özen D, Ölmez M, Altintas E, Kaya Y, Toklu R, Sariçiçek T, Tipi OU, Benli GE, Tasdelen I, Tura A, Ucar A, Ekci B, Bilgili AC, Kiraz IN, Aksoy H, Cinar EN, Basak A, Erdem M, Kayacan S, Sahin C, Uysal M, Karakus K, Altiner S, Demirci ZS, Eren E, Yavas M, Tiftik E, Aksoy AB, Karagöz E, Sabanci R, Tümer SS, Kargici K, Banaz T, Abdulrahman SMF, Yesilsancak M, Yanikoglu E, Karabulut A, Yilmaz D, Bilicen G, Yarenci E, Demiroglu Y, Sunal A, Baykan B, Abbasguliyev H, Mutlu V, Mahmoudi Y, Dossa SAA, Mizan SR, Demirtas B, Cavus T, Yuksek A, Mazlum SS, Yelkenci C, Baran T, Satilmisoglu M, Sahin AZ, Kilinç A, Isik K, Yumurtaci Ö, Emin A, Girit Ç, Yildirak MK, Senyigit E, Güldag A, Söyleyici B, Aytin YE, Akay FE, Iskan NG, Mutlu B, Sunay AO, Ablett AD, Tie-Gill T, Ramsay G, De Paola L, McGuckin S, Alshakhs A, Ahmeidat A, Wong J, Goergen N, Ali Z, Mullarkey L, Bath MF, Walshe R, Lewis E, Berry B, Moneim J, Mookerjee S, Christy S, Ojofeitimi O, Carroll L, Hylands A, Delaugere LP, Reveendran D, Coulter C, Ralston C, Laverty L, Gallagher P, Ahmed A, Yeo YQ, Elliott D, Bennett J, Mcnamara M, Sivarajah S, Dunmore C, Aitken G, Nair M, Aly MH, Buari M, Farhan-Alanie MMH, Ahmed K, Sheikh Z, Monks M, Lehmann J, Rotimi O, Bell T, Limnatitou D, Gormley S, Taleongpong P, Patel V, Macgregor L, Amini S, Turner C, Dwyer-Hemmings L, Busuttil A, Powell J, Hensher C, Vivian F, Wcislo K, Millar Z, Hirosue S, Ogunmwonyi I, Nakakande D, Kwek I, Gaze H, Pillai S, Khoury G, Powell T, Maleyko I, Sangheli A, Ransome M, Isse M, Aromolaran O, Bholah H, Anbarasan J, Rehman S, Hu E, Timms S, Reynolds W, Hotchkies A, Misra V, Suresh G, Murray V, Theocharidou L, Malik T, Janmohamed I, Carhart B, Khan A, Asif A, Hullait R, Quinn P, Rylance A, Butt S, Leathes J, Finch BJ, Rajathasan TP, Jeddy H, Kyaw HA, Wong N, Karelia S, Clements JM, Rainey M, Joshi N, Rahman A, Gallagher M, Rebuffa N, Abdelgalil R, Lai RSY, Laurence N, Thomas S, Green C, Frostick R, Khera R, Povey M, Wong HL, McCusker C, Hlukha L, Pike G, Kamel F, Thakkar R, Donaldson C, Campos MS, Bhahirathan Y, Herron J, Bradbury M, Osunronbi T, Tam LYC, Kaabneh AK, Lawther J, Fisher P, Tribedi T, Moosa A, Ramdin A, Goble M, Downs E, Wheldon L, Baggus E, Mandal A, Nayeem A, Ahmed S, Fradley W, Wilson C, Gallagher S, Criswell T, Ward J, Mukkavilli A, Stubbs B, Fordyce W, Suchdev N, Lim SW, Tew ZY, Sookramanien SR, Chan A, Bointas G, Paul M, Ward KL, Bagnall M, Pherwani SA, Wang K, Mitchell L, Heyworth J, Ayyar S, Obukofe R, Polson R, Mason D, Mackenzie E, Russell C, Doyle N, Habib Z, Zardab M, Sartaj F, Farooq H, Tabibi M, Drury DJ, James SJ, Barnett R, Cahya E, Lou G, Coyle M, Homyer K, Zhu LY, Woods M, Chang J, O'Callaghan H, Suchett-Kaye I, Mihailidis TH, Alawattegama H, Seite E, Barrett A, Riordan E, Lam W, Dowdeswell M, Mulvenna C, Netke T, Awokoya O, Gurowich L, Dhera K, Hayat S, Williams L, Tincknell L, Spazzapan M, Teeling F, Sysum K, Latter J, Latter M, Khan S, Woodmass M, Hayden H, Kisiel A, Ali Y, Husain S, Arnold A, Pedersen AC, Cunha P, Ahmed M, Al Zawawi S, Kudva V, Liu FY, Theodoropoulou K, Miscampbell M, Robinson AV, Johnston J, Dharni A, Lamb S, Westerman T, Evans E, Campbell L, Gillespie M, Cheong CM, Kulathevanayagam K, Varghese A, Ike SI, Chu TSM, Baljer B, Mogg JAW, Rai P, Claireaux HA, Williams M, Smillie R, Goetz J, Appleby E, Fadipe T, Vaughan-Burleigh S, Mondal A, Jovaisaite A, Shah SM, Khalid N, Gutmann D, Davison S, Alame YJ, Syed L, Owen WJ, Ahsan SD, Kalderon R, Anthony-Uzoeto U, Hall CM, Zheng S, Wynter K, James C, Sapre D, Ghosh R, Baird J, Cockburn L, Blackwood O, Nadama HH, Simpson W, Jeong S, Bishop S, Bate R, Hobson C, Adam AH, Redclift C, Do J, Adeleye O, Poli F, Batterham A, Brown S, Parekh JN, Clay W, Pieri K, Jackson A, Brown S, Saxena A, Gurung B, Oyebola T, O'Brien F, Djeugam B, Gardezi S, Ul-Hasan S, Martin-Hernandez MP, Sisley M, Modi S, Antakia R, Elbayouk A, Soh YJ, Mather J, Yusuf Z, Al-Sarraf Z, Naja M, Rassool SB, Convill J, Nikookam Y, Warsame A, Tam JPH, Pace C, Kiandee M, Ridwan R, Carey C, Hirri F, McMillan MJA, Ling JJ, Powell-Chandler A, Pendelbury L, Kerimzade K, Tang A, Howard EO, Humayun S, Wadsworth OJ, Tan K, Abdelhameed F, Haglund C, Radnaeva I, Hu N, Rambhatla S, Waldron D, Madahar P, Malik S, Campbell A, Meney LC, Ibrahim I, Kang CK, Chiu JZJ, Livie V, Ibrahim B, Khalil M, Pooley G, Shishkin B, Gorgievska R, Docherty J, Southgate A, Coomes A, McGee F, Flanagan S, Thakrar C, Tan QJ, Anwar H, Clough R, Chrisp B, Cassels J, Cross GWV, Ragavoodoo A, Mercer L, Mercer C, Refalo A, Hadley R, McTighe A, Farrow F, Brodie A, Davis G, Shah DR, Bowers C, Patel S, Morice O, Burzic A, Cheung J, Shashidhara A, Theodoraki G, Birk J, Ong A, Ng MPE, Wong RTW, Maese S, Yeap B, Iqbal Z, Melaugh T, Perchard W, Scurr T, Davidson K, Campbell E, Kelk L, Ghosh A, Gibbins A, Mala D, Loizidou A, Hall O, Mecia L, Hew C, Varathan K, Tong L, Chandrasekar B, Giacci L, Buchanan E, O'Connell M, Kwak SY, Ong EH, Gardner S, Lim J, Maden C, Illahi M, Hale J, Tan ZX, Edwards S, Stahl R, Stahl J, Hickman A, Collett D, Goolam-Mahomed Z, Allen B, Atiyah A, Ahmad H, Jones J, McGregor O, Ogundiya E, Gan FW, Boulbadaoui A, Kirnon-Jackman O, Lim QX, Peckham H, Yeoh T, Yong SQ, Chen JY, Siva S, Sam ZH, Gilani M, Goh YN, Muthukumar MG, Phillips S, Makin-Taylor R, Tjoakarfa J, Giri A, Suresan S, Thavayogan R, Hey CY, Thomas P, Johnson TA, Williams RI, Rashid A, Kushairi A, Rais A, James A, Bugelli M, Chechelnitskaya Y, Sandhu N, Toh C, Tandon R, Gray M, Kumar A, Ciurleo C, Nyamali I, Hiremath S, Sinha S, Chowdhary M, Bradley E, McTiernan M, Macdonald S, Sharkey S, McLaughlin N, Amey C, Kraria L, Skan O, Kind C, Findlay JM, Tupper P, Van Rhee C, Honeyman SI, Menon G, Ahmed M, Jegatheeswaran L, Griffiths N, Madhavan A, Warne M, Malcolm FL, Lessware T, Wilkerson HT, Chatterjee-Woolman S, Yoong A, Ahmed WUR, Longshaw A, Flannery O, Green R, Leaning M, Cragg J, Sharriff H, Doherty C, Ganesananthan S, Kwan KWL, Sanders-Crook L, Bhatia S, Eames S, Lewis F, Kirupananthan P, Boh ZY, Dass S, Soma A, Newton A, Hill M, Shafiq Y, Brkljac M, Boyce L, Jasionowska S, English WJ, Lam S, Chipeta C, Yilmaz D, Jain C, Garofalidou T, Novotny SA, Locke S, Bowman C, Begaj A, Murphy C, Radcliffe K, Chong JT, Poustie M, Jeffrey E, Chaudhury N, Rajendran K, Akbar Z, Walters B, Kulendrarajah B, Tran N, Shrestha S, Parmar S, Gallagher C, Hennessy L, Pentti E, Badhrinarayanan S, Fung A, Mansoor M, Kenny R, Kan P, Lee DE, Khosla S, Samake M, Shaban F, Aftab R, Gough M, Woodburn B, Vayalapra S, McMurrugh K, Wong C, Jimulia D, Deol S, Pike S, Embury-Young Y, Turner T, Patel M, Kilgallon E, Keating R, Walsh A, Khan H, Logue G, Orekoya M, Alasmar M, Charalambides M, Llavall AC, Williamson E, Bharwada Y, Zearmal S, Evans H, Panikkar M, de la Cruz G, Caplan J, Ruparelia A, Tanvir T, Soare C, Pang YL, Trotter J, Zaidi A, Thakrar V, Pulickal P, Ahmed H, Parnell J, Khan H, Lennock S, Ford V, Pyc W, Brignall R, O'Neill D, Hanna R, Kane R, Nicola M, Rajput K, Xiao Y, Warner C, Michael S, Wright E, Juniper S, Thompson E, Hoskyns L, Kanitkar A, Ross C, Unsworth A, Rshaidat H, Demarre K, Chiang A, Bareh A, van Dellen J, Faqihinejad C, Gadhvi A, Grant R, Lewsey J, Morris A, Martin H, McClarty C, Sanyal S, Alsaif A, Palkhi A, Bhopal S, Burford C, Huq T, Sloper W, Irwin E, Matthews L, Ngu WS, Hosfield T, Muneeb F, Page O, Zeb E, Coey J, Al-Azzawi A, McIntosh J, Vucicevic A, Hughes M, Brooks L, Fanibi B, Dixon M, Njoku P, Morris D, Jobson J, Chowdhury H, Joseph N, Zulkefley N, Hunt G, Christodoulou T, Wright O, Soman S, Jamal M, Beqiri S, Borgas P, Christie S, Pereira F, Browne S, Yiu J, Dworkin A, Brayley J, Palmer A, Charalambos M, Jones CS, Toner S, Cowden R, Lee L, Nicol P, Holman O, Imtiaz M, Albert V, Leung SP, Erotocritou M, Wong J, Stroud R, Mason D, Wilkin R, Thomson W, Mackee L, Kler A, Reynolds L, Mohamed SH, Majeed Y, Fakim B, Jones A, Kowal M, Liversedge G, Carrington Z, Windebank J, Izzarina A, Akbani U, Craven J, Aldarragi A, Harding S, Millward A, Shortland TC, Bedford M, Stroud R, Obukofe R, Mackenzie E, Gopalan V, Midgen A, Khadka P, Cheng O, Taneja S, Manobharath N, Kok JY, Lim DWE, Buick T, Boland M, Piya S, Devlin R, Fairfield CJ, George RJ, Rahi M, Zaman S, Hajiev S, Ross T, Owen M, Crisp E, Thompson C, Charalambous A, Hollywood JL, Saiyed A, Hammond RFL, Matthews J, Mendonca V, Spinty J, Khan K, Cheng J, Glynn N, Muhammad U, Khan M, Anderson L, Mccormack K, Mak J, Patrawala S, Milinkovic N, Schofield R, Chauhan M, Hartley L, Hind J, Ashworth I, Nelson L, Ratnasingham D, Akbari K, Whitehead T, Dimitriadis S, Marshall K, Flint EJ, Curran M, Horner C, Heybourne A, Morgan H, Wickstone C, Panagiotou D, O'Connell E, Dean K, Iqbal R, Walsh L, Yu N, Rana N, Massie E, Ng J, Jung M, Lee YD, Harris M, White S, Delibegovic S, Boev B, Tonchev P, Prochazka V, Örhalmi J, Riško J, Skalický A, Chrz K, Ravn S, Ojakããr A, Duchalais E, Dörr-Harim C, Herrle F, Koutserimpas C, Giraudo G, Armellini A, Ruzzenente A, Mazzeo C, De Padua C, Luc AR, Maroli A, Vitali M, Ceccarelli G, Gusai GP, Quattromani R, Virgilio E, Berti S, Mulas S, Di Mola FF, Papagni V, Tuminello F, Magnoli M, Vittori L, Longheu A, Loche GA, Braccio B, De Luca E, Resta G, Ancans G, Tamosiunas A, Petrulionis M, Abdulrahman N, van de Pas KGH, Thomas G, Brandsma AM, Davids J, Rottier SJ, de Roy van Zuidewijn D, Hawkins R, Ong HI, Li Y, Desmond B, Winstanley J, Martins M, Rosete M, Americano M, Santos M, Frade S, Senhorinho R, Peixoto R, João AA, Alves-Vale C, Lamas M, O'Connor DB, Hoo M, Gopaul A, Scanlon K, O'Dwyer N, Negoi I, Jovanović M, Panyko A, De Lima H, Van Vuuren S, Centeno A, Bernado IR, Señorans MPG, Amor LG, Ramírez AC, Abrisqueta J, Gomez ME, Arroyo A, Cerdán C, Romeu NG, Forero-Torres A, Enriquez-Navascues JM, Collado-Roura F, Curchod P, Gaspar S, Imadalou L, Mutlu D, Akyol C, Uygur FA, Eray IC, Biyiklioglu O, Çetin MF, Isik AE, Karip B, Dogan H, Sarıgül L, Tunc E, Aydin T, Bodur S, Karabulut K, Francis AA, Al-hadithi A, Lau ISF, Smith E, Mahapatra S, McAuliffe O, Francis AA, Imam L, Akram B, Hossaini S, Davies R, Ko M, Collins J, Pandya A, Reilly S, Archer J, Livie J, Chaudhry FA, Ntakomyti E, Diallo R, Bylinski T, Wright J, Lawday S, Masiha E, Tung J, Shirazi B, Neilson A, Epton S, Patel N, Trussell S, Couldrey A, Donnelly C, Eftychiou S. Safety of hospital discharge before return of bowel function after elective colorectal surgery. Br J Surg 2020; 107:552-559. [PMID: 31976560 DOI: 10.1002/bjs.11422] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2019] [Revised: 10/06/2019] [Accepted: 10/08/2019] [Indexed: 02/05/2023]
Abstract
BACKGROUND Ileus is common after colorectal surgery and is associated with an increased risk of postoperative complications. Identifying features of normal bowel recovery and the appropriateness for hospital discharge is challenging. This study explored the safety of hospital discharge before the return of bowel function. METHODS A prospective, multicentre cohort study was undertaken across an international collaborative network. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The main outcome of interest was readmission to hospital within 30 days of surgery. The impact of discharge timing according to the return of bowel function was explored using multivariable regression analysis. Other outcomes were postoperative complications within 30 days of surgery, measured using the Clavien-Dindo classification system. RESULTS A total of 3288 patients were included in the analysis, of whom 301 (9·2 per cent) were discharged before the return of bowel function. The median duration of hospital stay for patients discharged before and after return of bowel function was 5 (i.q.r. 4-7) and 7 (6-8) days respectively (P < 0·001). There were no significant differences in rates of readmission between these groups (6·6 versus 8·0 per cent; P = 0·499), and this remained the case after multivariable adjustment for baseline differences (odds ratio 0·90, 95 per cent c.i. 0·55 to 1·46; P = 0·659). Rates of postoperative complications were also similar in those discharged before versus after return of bowel function (minor: 34·7 versus 39·5 per cent; major 3·3 versus 3·4 per cent; P = 0·110). CONCLUSION Discharge before return of bowel function after elective colorectal surgery appears to be safe in appropriately selected patients.
Collapse
|
41
|
Shen X, Laher F, Moodie Z, McMillan AS, Spreng RL, Gilbert PB, Huang Y, Yates NL, Grunenberg N, Juliana McElrath M, Allen M, Pensiero M, Mehra VL, Der Meeren OV, Barnett SW, Phogat S, Gray GE, Bekker LG, Corey L, Tomaras GD. HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens. Sci Rep 2020; 10:2093. [PMID: 32034163 PMCID: PMC7005751 DOI: 10.1038/s41598-020-57491-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2019] [Accepted: 12/17/2019] [Indexed: 11/09/2022] Open
Abstract
In the RV144 trial, vaccine-induced V1V2 IgG correlated with decreased HIV-1 risk. We investigated circulating antibody specificities in two phase 1 poxvirus prime-protein boost clinical trials conducted in South Africa: HVTN 097 (subtype B/E) and HVTN 100 (subtype C). With cross-subtype peptide microarrays and multiplex binding assays, we probed the magnitude and breadth of circulating antibody responses to linear variable loop 2 (V2) and conformational V1V2 specificities. Antibodies targeting the linear V2 epitope, a correlate of decreased HIV-1 risk in RV144, were elicited up to 100% and 61% in HVTN 097 and HVTN 100, respectively. Despite higher magnitude of envelope-specific responses in HVTN 100 compared to HVTN 097 (p’s < 0.001), the magnitude and positivity for V2 linear epitope and V1V2 proteins were significantly lower in HVTN 100 compared to HVTN 097. Meanwhile, responses to other major linear epitopes including the variable 3 (V3) and constant 5 (C5) epitopes were higher in HVTN 100 compared to HVTN 097. Our data reveal substantial differences in the circulating antibody specificities induced by vaccination in these two canarypox prime-protein boost trials. Our findings suggest that the choice of viral sequences in prime-boost vaccine regimens, and potentially adjuvants and immunogen dose, influence the elicitation of V2-specific antibodies.
Collapse
|
42
|
Guthrie JL, Strudwick L, Roberts B, Allen M, McFadzen J, Roth D, Jorgensen D, Rodrigues M, Tang P, Hanley B, Johnston J, Cook VJ, Gardy J. Comparison of routine field epidemiology and whole genome sequencing to identify tuberculosis transmission in a remote setting. Epidemiol Infect 2020; 148:e15. [PMID: 32014080 PMCID: PMC7019559 DOI: 10.1017/s0950268820000072] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2019] [Revised: 12/04/2019] [Accepted: 01/09/2020] [Indexed: 11/29/2022] Open
Abstract
Yukon Territory (YT) is a remote region in northern Canada with ongoing spread of tuberculosis (TB). To explore the utility of whole genome sequencing (WGS) for TB surveillance and monitoring in a setting with detailed contact tracing and interview data, we used a mixed-methods approach. Our analysis included all culture-confirmed cases in YT (2005-2014) and incorporated data from 24-locus Mycobacterial Interspersed Repetitive Units-Variable Number of Tandem Repeats (MIRU-VNTR) genotyping, WGS and contact tracing. We compared field-based (contact investigation (CI) data + MIRU-VNTR) and genomic-based (WGS + MIRU-VNTR + basic case data) investigations to identify the most likely source of each person's TB and assessed the knowledge, attitudes and practices of programme personnel around genotyping and genomics using online, multiple-choice surveys (n = 4) and an in-person group interview (n = 5). Field- and genomics-based approaches agreed for 26 of 32 (81%) cases on likely location of TB acquisition. There was less agreement in the identification of specific source cases (13/22 or 59% of cases). Single-locus MIRU-VNTR variants and limited genetic diversity complicated the analysis. Qualitative data indicated that participants viewed genomic epidemiology as a useful tool to streamline investigations, particularly in differentiating latent TB reactivation from the recent transmission. Based on this, genomic data could be used to enhance CIs, focus resources, target interventions and aid in TB programme evaluation.
Collapse
|
43
|
Laher F, Moodie Z, Cohen KW, Grunenberg N, Bekker LG, Allen M, Frahm N, Yates NL, Morris L, Malahleha M, Mngadi K, Daniels B, Innes C, Saunders K, Grant S, Yu C, Gilbert PB, Phogat S, DiazGranados CA, Koutsoukos M, Van Der Meeren O, Bentley C, Mkhize NN, Pensiero MN, Mehra VL, Kublin JG, Corey L, Montefiori DC, Gray GE, McElrath MJ, Tomaras GD. Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines. PLoS Med 2020; 17:e1003038. [PMID: 32092060 PMCID: PMC7039414 DOI: 10.1371/journal.pmed.1003038] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2019] [Accepted: 01/31/2020] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND HVTN 100 evaluated the safety and immunogenicity of an HIV subtype C pox-protein vaccine regimen, investigating a 12-month booster to extend vaccine-induced immune responses. METHODS AND FINDINGS A phase 1-2 randomized double-blind placebo-controlled trial enrolled 252 participants (210 vaccine/42 placebo; median age 23 years; 43% female) between 9 February 2015 and 26 May 2015. Vaccine recipients received ALVAC-HIV (vCP2438) alone at months 0 and 1 and with bivalent subtype C gp120/MF59 at months 3, 6, and 12. Antibody (IgG, IgG3 binding, and neutralizing) and CD4+ T-cell (expressing interferon-gamma, interleukin-2, and CD40 ligand) responses were evaluated at month 6.5 for all participants and at months 12, 12.5, and 18 for a randomly selected subset. The primary analysis compared IgG binding antibody (bAb) responses and CD4+ T-cell responses to 3 vaccine-matched antigens at peak (month 6.5 versus 12.5) and durability (month 12 versus 18) timepoints; IgG responses to CaseA2_gp70_V1V2.B, a primary correlate of risk in RV144, were also compared at these same timepoints. Secondary and exploratory analyses compared IgG3 bAb responses, IgG bAb breadth scores, neutralizing antibody (nAb) responses, antibody-dependent cellular phagocytosis, CD4+ polyfunctionality responses, and CD4+ memory sub-population responses at the same timepoints. Vaccines were generally safe and well tolerated. During the study, there were 2 deaths (both in the vaccine group and both unrelated to study products). Ten participants became HIV-infected during the trial, 7% (3/42) of placebo recipients and 3% (7/210) of vaccine recipients. All 8 serious adverse events were unrelated to study products. Less waning of immune responses was seen after the fifth vaccination than after the fourth, with higher antibody and cellular response rates at month 18 than at month 12: IgG bAb response rates to 1086.C V1V2, 21.0% versus 9.7% (difference = 11.3%, 95% CI = 0.6%-22.0%, P = 0.039), and ZM96.C V1V2, 21.0% versus 6.5% (difference = 14.5%, 95% CI = 4.1%-24.9%, P = 0.004). IgG bAb response rates to all 4 primary V1V2 antigens were higher 2 weeks after the fifth vaccination than 2 weeks after the fourth vaccination: 87.7% versus 75.4% (difference = 12.3%, 95% CI = 1.7%-22.9%, P = 0.022) for 1086.C V1V2, 86.0% versus 63.2% (difference = 22.8%, 95% CI = 9.1%-36.5%, P = 0.001) for TV1c8.2.C V1V2, 67.7% versus 44.6% (difference = 23.1%, 95% CI = 10.4%-35.7%, P < 0.001) for ZM96.C V1V2, and 81.5% versus 60.0% (difference = 21.5%, 95% CI = 7.6%-35.5%, P = 0.002) for CaseA2_gp70_V1V2.B. IgG bAb response rates to the 3 primary vaccine-matched gp120 antigens were all above 90% at both peak timepoints, with no significant differences seen, except a higher response rate to ZM96.C gp120 at month 18 versus month 12: 64.5% versus 1.6% (difference = 62.9%, 95% CI = 49.3%-76.5%, P < 0.001). CD4+ T-cell response rates were higher at month 18 than month 12 for all 3 primary vaccine-matched antigens: 47.3% versus 29.1% (difference = 18.2%, 95% CI = 2.9%-33.4%, P = 0.021) for 1086.C, 61.8% versus 38.2% (difference = 23.6%, 95% CI = 9.5%-37.8%, P = 0.001) for TV1.C, and 63.6% versus 41.8% (difference = 21.8%, 95% CI = 5.1%-38.5%, P = 0.007) for ZM96.C, with no significant differences seen at the peak timepoints. Limitations were that higher doses of gp120 were not evaluated, this study was not designed to investigate HIV prevention efficacy, and the clinical significance of the observed immunological effects is uncertain. CONCLUSIONS In this study, a 12-month booster of subtype C pox-protein vaccines restored immune responses, and slowed response decay compared to the 6-month vaccination. TRIAL REGISTRATION ClinicalTrials.gov NCT02404311. South African National Clinical Trials Registry (SANCTR number: DOH--27-0215-4796).
Collapse
|
44
|
Chapman SJ, Clerc D, Blanco-Colino R, Otto A, Nepogodiev D, Pagano G, Schaeff V, Soares A, Zaffaroni G, Žebrák R, Hodson J, Blanco-Colino R, Chapman SJ, Glasbey JC, Pata P, Pellino G, Sgrò A, Soares A, Elst T, Van Straten S, Knowles CH, Nepogodiev D, Hodson J, Borakati A, Bath MF, Yasin IH, Mclean K, Arthur T, Kovacevic M, Delibegovic S, Karamanliev M, Swamad M, Žebrák R, Paramasivam R, Martensen A, Larsen HM, Rädeker L, Frey PE, Kechagias A, Venara A, Duchalais E, Ioannidis A, Pata F, Pellino G, Pasquali S, Sgrò A, Simioni A, Farina V, Podda M, Lorenzon L, Schaeff V, Otto A, Jakubauskas M, Elst TR, Chu M, Fagan PVB, Wells CI, Alagoa João A, Soares A, Juloski J, Clerc D, Ciubotaru C, Popescu S, Yanishev A, Lee S, Ozkan BB, Yagız Sen A, Aktas MK, Baki BE, Yüksek B, Glasbey JC, Kamarajah S, Mclean K, Borakati A, Yasin IH, Khaw RA, Mills E, Goodson R, Thakral N, Ablett AD, Adra M, Kwek I, Khan SM, Quinn P, Manley LR, Badran A, Ramjeeawon A, Campbell A, Tan HL, Rye DS, Rajaraman N, Norman JG, Vutipongsatorn K, Solomou G, Akhbari M, Ali A, Murray V, Baker DM, Brandao BD, Stainer B, Thavayogan R, Jones D, Onafowokan OO, Gharooni A, Dabab N, Carlton-Carew S, Kungwengwe G, Gabriel M, Sewart E, Shortland TC, Lawday S, Pockney P, Dawson A, Arthur T, Brumfitt CD, Stewart P, Ng B, Luong JK, Delibegovic S, Ivanov V, Borisova A, Neykov V, Kunčarová K, Kološová B, Antonova T, Farkašová M, Žebrák R, Harbjerg JL, Brandsborg S, Brinck S, Kjaer MD, Mark-Christensen A, Unbehaun KP, Dalsgaard P, Lycke KD, Kechagias A, LeNaoures P, Duchalais E, Brigand C, Dumange E, Gout M, Moehwald C, Prem M, Alhalabi O, Sliwinski S, Krupp J, Gablenz E, Schmitzer L, Kopp A, Steinle J, Gsenger J, Pohl LJ, Riccardi M, Christodoulou IM, Konstantinidis M, Machairas N, Zoikas A, Balalis D, Manatakis DK, Aguilera ML, Sgrò A, Simioni A, Marano L, Fleres F, Lovisetto F, Sasia D, Segalini E, Pata G, Lucchi A, Sagnotta A, Campagnaro T, Petrelli F, Gallo G, Papandrea M, Testa V, Sinibaldi G, Di Candido F, Colombo F, Perrone G, Aresu S, Biancafarina A, Canonico G, Pagnanelli M, Curletti G, Bini R, Manzoni Garberini A, Impellizzeri H, Cillara N, Tutino R, Picciariello A, Coletta D, Savino G, Ferrara F, Tamini N, Talamo G, Parini D, Giamundo P, lo Conte A, Pagano G, Ripetti V, Pesce A, Menduni N, Pellino G, Giudicissi R, Podda M, Goldin E, Rega D, Belli A, Andriola V, Gordini L, Pata F, Foppa C, Piccolo G, Birindelli A, Ferrari C, Ballarini Z, Tirelli F, Milone M, De Rosa M, Pipitone Federico NS, Molteni B, Tilocca PL, Sancini G, Piozzi GN, Lauretta A, Poillucci G, Mulas S, Schaeff V, Otto A, Jakubauskas M, Simcikas D, Portelli L, Wijnbergen JWM, Dinger TL, Doesschate SFH, Dalen ASHM, Bos DD, Hansmann M, Medina Feliz J, Kuiper SZ, Abdulrahman Z, Pruijssers SR, Farik S, Elliott BM, Geneta VP, Chu M, Wilton S, Kandelaki H, Peng SL, Campbell S, Lim YK, Yassaie SS, Murray M, Fagan PVB, Haran C, Tan J, Castro J, Laranjeira A, Catarino S, Neves-Marques C, Correia JG, Vieira BN, Quintela AC, Serra ML, Maciel J, Cunha M, Aparício DJ, Neves J, Azevedo J, Romano M, Eiró F, Romano J, Monteiro C, Claro M, Almeida MR, Peyroteo M, Machado ND, Capote H, Ferreira M, Sousa X, Devesa H, Cavadas D, Guerreiro I, Costa M, Salman M, English C, Mohammed N, Popescu S, Yanishev A, Litvin A, Ćuk VV, Mészárosová K, Van Straten S, Jaich R, De Lima H, Brooks S, Marx M, Nshalati Salvation M, Clerc D, Blaser B, Piazza G, Gagliardi B, Serin H, Yagız Sen A, Yurdaor SS, Aktas MK, Arslan E, Kopac O, Uyanik A, Ozmen BB, Tiftik E, Aksoy B, Yalcinkaya A, Ozoglu F, Kocer MD, Bilicen G, Cinar EN, Uslu Ö, Kaya Y, Wong J, Farhan-Alanie MMH, Suresh G, Asif A, Finch BJ, Bhahirathan Y, Herron J, Yi Tew Z, Obukofe R, Russell C, Suchett-Kay I, Netke T, Williams L, Kisiel A, Liu FY, Claireaux H, James P, Mondal A, Kalderon R, Nadama HH, Al-Saraff Z, Tam JPH, Powell-Chandler A, Wood F, Campbell A, Gorgievska R, Ragavoodoo A, Thakrar C, Rojoa D, Palmer C, Davidson K, Giacci L, Hale J, Gan FW, Makin-Taylor R, Hey CY, Toh C, Findlay JM, Griffiths N, Ganesananthan S, Jasionowska S, Poustie M, Wong C, Turner T, Pyc W, Sloper W, Warner C, Coey J, Mason D, Sait S, Kowal M, Shortland TC, Owen M, Saiyed A, Ashworth I, Akbari K, Curran M, Martin P, Parker D, Dawson A, Kwok K, Lye C, Pockney P, Ghaly M, Sammour T, Lewis D, Mundasad R, Wilkes A, Ctercteko G, Stewart P, Delibegovic S, Maslyankov S, Dimov R, Iliev S, Dimitrov D, Marek F, Örhalmi J, Skalický P, Skalický T, Chrz K, Christensen P, Worsøe J, Kristensen ES, Emmertsen KJ, Loeve US, Duchalais E, Mihaljevic AL, Herrle F, Konstantinidis KM, Manatakis DK, Korkolis D, Karanikas I, Aguilera ML, Vincenti L, Anania G, Borghi F, Agresta F, Maretto I, Parisi A, Bucci L, De Palma G, Guglielmi A, Cucinotta E, La Torre F, Cianchi F, Guerrieri M, Lauretta A, Trompetto M, Persiani R, Micheletto G, Rega D, Belli A, Cantafio S, Lovisetto F, Ronconi M, Bisagni PAG, De Prizio M, Tamini N, Sinibaldi G, Franceschi A, Galleano R, Cavallini M, Brescia A, D'Ambra L, Benevento A, Niolu P, Calgaro M, Colangelo E, Grottola T, Altomare DF, Puleo S, Salamone G, Pietrabissa A, Poggioli G, Ripetti V, Erdas E, Ottonello R, Canonico G, Tonini V, Selvaggi F, Sammarco G, Ceccarelli G, De Nisco C, Surgo D, Taglietti L, Ozolins A, Sivinš A, Poskus T, Psaila J, Bemelman WA, Graat LJ, Langenhoff B, Wijnhoven BPL, Ven AHW, Poelman M, Stassen LPS, Slooter G, Acherman YIZ, Hoff C, Gerhards MF, Stommel MWJ, Hazebroek EJ, Geloven AAW, Schasfoort RA, Leeuwen BL, Tuynman JB, Tilburg MWA, Boerma EG, Sharma P, Jenkins B, Bissett IP, Peng SL, Herd A, Gordon A, Vernon D, Omundsen M, Ly J, Reddy A, Bonnet G, Harmston C, Morales M, Francisco V, Costa S, Manso A, Amorim E, Pereira J, Cardoso J, Ourô S, Caratão M, Nascimento C, Ribeiro da Silva B, Taranu V, Dias R, Devesa H, Mendes J, Allen M, Silva A, Carlos S, Barbosa E, Carneiro C, Ramos L, Maciel J, Lencastre L, Martins R, Silva-Vaz P, Ridgway PF, McNamara DA, Cahill R, Hogan A, Larkin J, O'Connell PR, Negoi I, Abelevich A, Ćuk VM, Vician M, Ede C, Sardiwalla I, Mulira S, Montwedi D, Oyomno M, Hübner M, Petermann D, Sauvain MO, Ozben V, Geçim IE, Disçi E, Rencuzogullari A, Kurt A, Bisgin T, Pehlivan M, Isik A, Onur E, Leventoglu S, Haksal MC, Erturk MS, Keskin M, Guner A, Tutcu Sahin S, Ozbalci GS, Pergel A, Albayrak D, Bruce D, Fearnhead N, Arthur J, Harron M, Beattie G, Titu L, Ali A, Saunders M, Phillips J, Dindyal S, Cresswell B, Gercek Y, Lee J, Linn T, Faulkner G, Lockwood S, Rees J, Charalabopoulos A, Campbell B, Kontovounisios C, Amarnath T, Johnson M, Epanomeritakis E, Vigs S, Nastro P, Gilliam A, Smolarek S, Wilson T, Orbell J, McIntyre R, Agarwal T, Hainsworth P, Patel P, Vijay J, Liu B, Dhruva Rao P, Roxburgh C, Vipond M, Youssef H, Thorn C, Schizas A, Denley S, Bowley D, Das K, Cuming T, Saha A, Chung L, Pitt J, Davis P, Jones O, Taylor M, Bhargava A, Haji A, Watson N, Bloom I, Singh B, Norwood M, Gurjar S, Stylianides N, Mirza S, Evans M, Williams G, Patil P, Hernon J, Finch G, Green S, Chapple K, Fafemi O, Warusavitarne J, Samee A, Carden C, Ong L, Verma K, Joseph A, Rawat N, Pinkney T, Oke O, Glen P, Maxwell-Armstrong C, Oliphant R, Garner J, Moug SJ, Middleton S, Lund JN, Smart NJ, Osborn G, Moore T, Raymond T, Knowles CH, Hany TS, Clarke R, Khera G, Brady R, Sellahewa C, Mason C, Torrance A, Lasithiotakis K, Knight J, Pullybank A, Ainsworth P, Reid F, Ramwell A, Maslekar S, George R, Skull A, Holtham S, Muhammad K, Lal R, Varcada M, Smith FM, Howlader M, Defriend D, Kirk S, Richards T, Evans C, Borg C, Telford K, Sarfraz N, Busby K, Hollingshead J, Speake D, Pawa N, West D, Chadwick M, Komolafe O, Richardson S, Thornton M, Goede A, Osborne C, Bandyopadhyay D, Foong J, Lee YJ, Liebenberg P, Mijalkov D, Wells A, Bull N, Ajmera A, Warburton T, Morgan S, Mahmoud A, Schachtel M, Mikhail B, Fomin I, Mekaeil B, Taylor N, Stevenson C, Drane A, Pahalawatta U, Lai LT, Debiasio A, Wong J, Jun HJS, Hengpoonthana R, Mendis DM, Robb PM, Lee HJ, Wyche AAB, Davis LT, Lee HJ, Chrimes A, Agarwal A, Zhao J, Williams S, Jayalath JMSN, Liebenberg P, Khor S, Muddasani T, Childs S, Ridgway S, Blefari NDA, Tam H, Puchalski N, Ngai C, Mackenzie J, Johnson N, Holmes M, Zuzek R, Saluja T, Gould T, Goh YK, Selvaraj T, Brumfitt CD, Beh YZ, Dudi-Venkata NN, Horne D, Borrow JL, Campbell C, Cousins G, Jackson L, Maheepala K, Zhao S, Holden E, Tutt L, Thompson B, Collins H, Louie F, Buckland B, Smith D, Chong C, Chua TH, Nayak C, Redmond J, Tan RR, Gramlick M, Teh JS, Ng SY, Britten-Jones P, Mohd Rosli R, Pham HDV, Jegathees T, Coulter-Nile SMCJ, Gosselink MP, Luong JK, Wang YL, Maciaszek M, Chrapko PS, Nair A, Thirugnanasundralingam V, Muir K, Salibasic M, Pavlov V, Paycheva T, Borisova A, Lyulenina E, Kolev N, Ivanov V, Nguen D, Mitkov Y, Mitkov E, Vladova P, Dimitrov V, Hussain M, Gabarski A, Ivanov T, Yotsov T, Ilieva I, Karamanliev M, Akisheva A, Shoshkova M, Nawaz E, Feradova H, Mladenov T, Neykov V, Jozaf V, Farkašová M, Klail T, Pös M, Adel A, Sotona O, Bartoš M, Amjad T, Malý O, Berec S, Hanušová M, Hurný M, Riško J, Ludvik M, Stercz M, Treskoň R, Pospíšil M, Hlaváčová L, Kunčarová K, Tomanová D, Chodora S, Houdek O, Novický R, Antonova T, Sobotková K, Cha S, šuta Kimle K, Jirankova K, Bujda M, Paclík A, Trap A, Jürgens-Lahnstein J, Storm M, Dalsgaard P, Damgaard I, Olawi F, Ehlem F, Raos M, Kristensen FP, Lycke KD, Bønnerup K, Unbehaun KP, Kjaer MD, Brandsborg S, Amiri S, Enevoldsen M, Harbjerg JL, Højgaard Pedersen J, Jepsen BN, Hillgaard TK, Erichsen SB, Nielsen CV, Madsen CP, Bjerke J, Skejø CD, Aabling RR, Sørensen JS, Mark-Christensen A, Kechagias A, Turunen A, Katunin J, Niskakangas M, Vignaud T, Frey S, Ricolleau C, Chanut F, Magnin J, Gout M, Seiboldt T, Beck L, Pohl LJ, Zamzow K, Betge F, Poncelet A, Truant M, Hauschild H, Neugebauer N, Schöning L, Simon SCS, Galata C, Karampinis I, Thäwel T, Seckler AM, Kerem C, Durdevic S, Ioannidis A, Antonakopoulos F, Konstantinidis M, Mathioulaki A, Chrysoheris P, Athanasopoulos PG, Kalles V, Spyrou I, Barkolias C, Paspala A, Machairas N, Papaconstantinou D, Spartalis E, Arkadopoulos N, Prodromidou A, Garoufalia Z, Balalis D, Zoikas A, Christodoulou IM, Mendez D, Rosales J, Flores M, Garcia M, Garcia A, Garcia M, Noriega Z, Torselli D, Aguilera ML, Rodriguez J, Lafranceschina S, Artioli E, Giaccari S, Nevoso V, Schimera A, Marino S, Geretto P, Pellegrino L, Borghi B, Sasia D, Marano A, Corino C, Cannata G, Giuffrida MC, Landra F, Pata G, Ongaro D, Baronio G, Raimondo S, Casiraghi S, Salvadori R, Savino G, Finotti E, Ciccioli E, Galgano A, Zuin M, Simioni A, Bettella A, Barina A, Vendramin E, Palano G, Schiavone D, Di Cintio A, Gemini A, Trastulli S, De Luca M, Sagnotta A, Desiderio J, Gubbiotti F, Cigognini M, Zaffaroni G, Maffioli A, Colombo S, Bondurri A, Sampietro G, Foschi D, Colombo F, Manigrasso M, Danzi M, Amato R, Anastasio L, Mastella F, Basile R, Peltrini R, Marra E, Luglio G, Pagano G, Giglio M, Manigrasso M, Anoldo P, Vertaldi S, Grimaldi L, Tammaro N, Pedrazzani C, Campagnaro T, Turri G, Lazzarini E, Conti C, Vulcano I, Bertilone E, Pintabona G, Viscosi F, Cerasari S, Galiffa G, Lapolla P, Coletta D, Del Basso C, Cirillo B, De Toma G, Fazzi K, Bini S, Coratti F, Montanelli P, Grandi S, Nelli T, Ben Khaled N, Cammelli F, Ferrini E, Billo ME, Tilocca PL, Marrosu AG, Scognamillo F, Pala C, Attene F, Carboni L, Ruggiu MW, Gabbas G, Marziali I, Mazzocato S, Petrelli F, Vergari R, Piazzai F, Kubolli I, Aggiusti A, Paolucci A, Ortenzi M, Olivieri M, Belluco C, Antona AD, Basso S, Morino M, Mistrangelo M, Testa V, Gallo G, Clerico G, De Santi G, Bitonti MF, Trompetto M, Pipitone Federico NS, Frattalone M, Tirelli F, Fico V, Santullo F, Belia F, Spinelli A, Marco M, Di Candido F, Bevilacqua M, Tringali D, Bevilacqua E, Panizzo V, Piozzi GN, La Manna V, Migliore G, Aversano A, Fares Bucci A, Marino F, Carbone F, Incollingo P, Romano FM, Giudicissi R, Zalla T, Baraghini M, Romoli L, Calussi M, Vellei S, Genzano C, Feroci F, Vita M, Barberis A, Serra D, Lucchi A, Grassia M, Romelli M, Ruggiero S, Percassi A, Ferrari C, Molteni B, Magri Piccinini A, Segalini E, Monti M, Magnoli M, Romano S, Gaetano P, Pilotta F, Baldassarre L, Perrone G, Bonati E, Aresu S, Saba A, Moretto G, Bacchion M, Impellizzeri H, Casaril A, Inama M, Creciun M, Ferrara F, Stella M, Gobatti D, Biancafarina A, Angelini M, Andolfi E, Miranda E, Scricciolo M, Provenza G, Cavallina G, Frezza B, Fontani A, Malatesti R, Pellicanò GA, Podda M, Anania M, Pulighe F, Cruccu A, Murru ML, Massaiu C, Balestra F, Pazzona M, De Nisco C, Giannella A, Santangelo M, Olivieri M, Frangella F, Magagnano D, Liberatore P, Brenna R, Giani A, Tirotta F, Famularo S, Angrisani M, Ceresoli M, De Rosa M, Rondelli F, Ceccarelli G, Angelucci GP, Scaramuzzo R, Larcinese A, Fioriti C, Picone E, Nardi M, Marano L, Castagnoli G, Bartoli A, Bellochi R, Spaziani A, Conti D, Poponesi V, Trippetti M, Amicucci S, Tazza G, Procacci P, Giovannini F, Basile E, Franceschi A, Caristo G, Pagnanelli M, De Nardi P, Rosati R, Marcocci G, Vignali A, Curletti G, Galleano R, Badran A, Malerba M, Percivale A, Ghazouani O, Reggiani L, Spirito C, Moschetta G, Cosmi F, Romeo G, Gasparrini M, Sucameli F, Gennai A, Moggia E, Bianchi C, Bonfante P, Macina S, Feleppa C, Talamo G, Imperatore M, Tenconi SM, Rausei S, Maioli D, Marchionini V, Pata F, Sparta C, Mura FA, Barmina M, Lorettu A, Rettaroli C, Mastino G, Ruggiu GV, Mura GA, Perrone BA, De Angelis M, Mereu A, Adamo V, Bianco C, Manzoni Garberini A, Ricciardiello M, Campanaro C, Panaccio P, Esposito LM, D'Ascanio F, Pietroletti R, Picciariello A, Chetta N, Aquilino F, Di Marco F, Amico A, Schembari E, Puglisi S, Licari L, Campanella S, Profita G, Falco N, Rotolo G, Venturelli P, Tutino R, De Marco P, Marcianò M, Sgrò A, Argenti F, Milani MS, Malabarba S, Giambartolomei G, Vella I, Gronchi F, Ruggieri A, Sancini G, Roggiani A, Balsamo F, Gori A, Cuicchi D, D'Alessio R, Benvenuto D, Gordini L, Erdas E, Podda F, Cappellacci F, Salaris C, Sanna S, Marcialis J, Mosino L, Peddis M, Melis S, De Donno G, Aru AC, Falsetti E, Parini D, Lanari J, D'Errico U, Bianchini S, Birindelli A, Figà F, Caiazzo A, Selvaggi L, Capozzolo A, Cerra C, Pirillo M, Papandrea M, Cravano S, Libri I, Laquatra N, Isabello A, Truškovs A, Bartnick A, Malcevs E, Machatschek MJ, Alm J, Lapsa S, Delorme M, Zeynalov F, Larnovskis J, Sauka J, Bodrov D, Gailumsis R, Wiemann AM, Müller NL, Jelovskis I, Deksnis D, Bauermeister Potts O, Slimbajevs T, Samalavicius NE, Simcikas D, Nutautiene V, Zeromskas P, Jurgaitis J, Aliosin O, Slepavicius A, Eismontas V, Kybransiene M, Dulskas A, Kuliavas J, Kavaliauskas P, Kavaliauskaite R, Poškus E, Danys D, KryŽauskas M, Mikalauskas S, Rackauskas R, Drungilas M, Poškus T, Jotautas V, Strupas K, Cachia C, Cefai C, Portelli L, Youssef Y, Degaetano D, Debono S, Sammut M, Cassar J, Sammut K, Looyen R, Dalen ASHM, Becker MAJ, Comert D, Molder L, Tromp J, Matthee E, Tissen YM, Brinkhuis E, Vries HS, 't Hart E, Beckers K, Bekker Y, Kakar S, Doesschate SFH, Smaalen TC, Veen OC, Dingemans SA, Brink LC, Vijgen GHEJ, Voort EMF, Pool A, Rest KLC, Haak T, Sluijpers NRF, Pruijssers SR, Molenaar CJL, Gordinou de Gouberville MC, Saleh S, Mens MA, Hoeks EM, Nieuwenhuizen S, Praag EM, Westerduin E, Smit MPCM, Lely SJ, Nasimi B, Gerdsen M, Stijns RCH, Leow TYS, Penningnieuwland G, Ruiter A, Ribbers T, Aarts CAM, Tulek MS, Jonge J, Kocak S, Alqethami HJ, Constansia R, Elst PC, Tissink MW, Grüter A, Vroom Y, Voeten DM, Feenstra T, Azzahhafi J, Bofarid S, Kip M, Saleh W, Franssen S, Boon CL, Franssen RJM, Romaen I, Jense MTF, D'Souza J, Pascoe R, Scott A, Stark E, Mulholland K, Lau WK, Smith B, Adams SIB, Shah N, Ling E, Young J, Peng SL, Jacobson A, Macfater H, Farik S, Chen SY, Kilpatrick K, Kim DH, Dixon S, Yassaie S, Welman D, Coulter J, Morreau M, Li E, Rankin A, Winders J, Skipworth C, Fagan PVB, Stanfield B, Henderson N, Chuang A, Maskill L, Ker H, McLaughlin SJP, Kearney J, Wilton S, Sprosen H, Kerckhoffs P, Alsadat R, Cherry R, Chapman DA, Singh N, Clucas A, Gatenby G, Kelly B, Ruppeldt P, McIntosh ND, Koh S, Wilms H, Dalzell F, Tewhaiti-Smith J, Kader T, Yam ST, Dahya D, Hardie Boys M, Fleischl W, Tan J, Skavysh A, Mouldey K, Elliott BM, Hu R, Edwards S, Matthews C, Aitken E, Walker M, Guerreiro I, Tomé M, Patrocinio S, Amado F, Batista A, Seabra J, Praxedes V, Monteiro N, Martins I, Serra ML, Santos TC, Lages RR, Pimentel A, Machado ND, Sá TC, Bernardes FM, Saraiva P, Almeida J, Mendes M, Fernandes V, Ribeiro A, Soares D, Costa M, Rosete M, Martins T, Miguel I, Martins J, Cunha MF, Melo J, Veiga DN, Rachadell J, Amorim E, Vareda R, Roseira J, Catarino S, Aveiro D, Couto M, Loureiro AR, Louro H, Queiros T, Castro B, Fonseca S, Carvalho L, Torre AP, Amado A, Leite M, Miranda P, Cunha C, Ferreira M, Cavadas D, Silva R, Pina S, Paixão I, Orelhas L, Santos J, Pacheco A, Rocha AF, Jervis MJ, Pedro V, Paixão V, Guerreiro A, Melo D, Correia D, Capella V, Moinhos T, Monteiro C, Silva M, Vieira BN, Silva AG, Galvão D, Mora A, Bettencourt R, Costa F, Gil I, Morgado J, Neves J, Mónica I, Oliveira S, Ribeiro H, Ferreira M, Guimarães N, Duarte M, Miranda J, Martins SF, Almeida MR, Parreira R, Faustino A, Medeiros N, Castro R, Soares B, Resendes M, Almeida P, Cruz A, Claro M, Vaz Pinto G, Sousa D, Costa Santos D, Silva A, Silva F, Fialho G, Reia M, Pratas N, Capote H, Costa C, Costa J, Morais S, Machado A, Horta V, Rocha-Melo M, Patrício J, Pereira M, Lima R, Cinza AM, Oliveira J, Velez C, Ferreira M, Borges F, Simões J, Eiró F, Botelho P, Cismasiu B, Alves D, Dias B, Costa C, Gonçalves JP, Valente P, Oliveira J, Freire L, Saraiva R, Moreira M, Fragoso M, Guimarães J, Cruz G, Aparício DJ, Ribeiro J, Borges da Ponte I, Almeida S, Martins AR, Louro T, Morgado M, Ferreira AS, Alves M, Oliveira N, Lérias R, Neves-Marques C, Estalagem I, Botelho C, Bártolo J, Fidalgo Antunes C, Cabral F, Brito Silva F, Dias Matos A, Santos M, Cunha R, Duarte M, Sousa M, Canotilho R, Peyroteo M, Correia AM, Martins PC, Jardim JAM, Domingos SP, Baião JM, Rocha BS, Lopes NMRO, Jordão DM, Correia JG, Ângelo MD, Caroço T, Romano M, Gomes JR, Monteiro RG, Varghese S, Boyle E, Aljohmani L, Alexander J, Graziadei V, McCaughey C, Jain A, Lee J, Ramanayake H, Sabnani R, Colon LF, Bansal N, Stephens I, Tan R, Sharma S, Doherty G, Fenn S, Mulhare E, Walsh M, Leavey C, Costigan O, Griffin S, Dockry É, Khogali E, Aly AK, McPhedran R, O'Gorman D, Vermeulen D, Dervan L, Kang SJ, Dixon O, Morrissey E, Compton M, Pentony AR, Piong CL, Nossier R, Hanna J, Sabir K, Eow SY, Ladak N, Boersma D, Kamath PJ, Soh TBW, Dyer AH, Chee SY, Tan IXH, Kelliher A, Adeusi L, Howarth N, McCawley N, O'Neill A, Jones MR, Saleh R, Singh A, Senaratne R, Kakodkar P, Subramanian I, Hogan A, Al-Salihi A, Vyas V, Vedadi A, Popescu SS, Piras K, Ciubotaru CI, Litvin A, Romanova E, Ponomarev N, Savchenko A, Yanishev A, Luzan R, Lutovinova E, Gavrilina A, Barkovskaya A, Kudelkina N, Topchubaev D, Radulović R, Miloševic K, Ćuk VV, Bojičić J, Juloski J, Genčić M, Janković U, Zubowicz M, Sucháň PK, Gerstmeier J, Mészárosová K, Brazitikou E, Fytrou E, Celik M, Dubovský M, Schmalenbeck J, Sautter SC, Ceyran H, Jaich R, Fitchat N, Mathebula S, Chauke J, Mculu W, Ngwenya Z, Withey K, Piperidis A, Toyi Y, Nicolaides A, Jaffer T, Sparke A, Van Staden N, McDuling CR, Claassen L, Kruger C, Weyers J, Marx M, Lecler J, Mignon G, Vanoni A, Henkens A, Jarrar G, Odovic M, Willemin M, Milliet O, Hahnloser D, Clerc D, Demartines N, Piazza G, Teixeira H, Pittet O, Haller ML, Gagliardi B, Huot A, Blaser B, Kefleyesus A, Bugmann A, Piotet LM, Meijers L, Kurtoglu GK, Sel EK, Isler VC, Yilmaz BS, Adiyaman C, Kara M, Demirkaya HC, Korkmaz HK, Pektas AM, Güner B, İşlek EC, Tombul HB, Boztuğ CY, Tınaz A, Yılmaz M, Karaman Y, Akın FA, Dansuk S, Başçavuş M, Kaya M, Kutlu B, Seker MC, Erten V, Memis U, Koçak ZB, Karapinar YE, Fakirullahoglu M, Uslu Ö, Köseoglu E, Yeni M, Aktas MK, Aykun N, Agca MH, Bilen C, Kilinc I, Atar C, Kilic V, Aktuna C, Aba M, Alim YE, Binbuga M, Kürklü Ö, Yurdaor SS, Ceylan C, Yilmaz S, Çalar SN, Yildirim N, Yavuz G, Yagız Sen A, Can B, Cesmeli E, Kus D, Kavar RC, Cevlik AD, Cengiz U, Turk EG, Yilmaz I, Yüksek B, Erdönmez H, Gürsoy F, Serin H, Kara H, Önsal U, Özbek M, Kasar PA, Ipor A, Özen D, Ölmez M, Altintas E, Kaya Y, Toklu R, Sariçiçek T, Tipi OU, Benli GE, Tasdelen I, Tura A, Ucar A, Ekci B, Bilgili AC, Kiraz IN, Aksoy H, Cinar EN, Basak A, Erdem M, Kayacan S, Sahin C, Uysal M, Karakus K, Altiner S, Demirci ZS, Eren E, Yavas M, Tiftik E, Aksoy AB, Karagöz E, Sabanci R, Tümer SS, Kargici K, Banaz T, Abdulrahman SMF, Yesilsancak M, Yanikoglu E, Karabulut A, Yilmaz D, Kuyumcu OF, Kutluk F, Emiroglu B, Aksoy B, Mollavelioglu B, Gereklioglu D, Guler M, Toprak S, Afsar HB, Guler SE, Alizade E, Baki BE, Alemdag G, Ulusahin M, Arslan E, Gul EB, Yildirim R, Semiz A, Bektur G, Tomas K, Bilicen G, Yarenci E, Demiroglu Y, Sunal A, Baykan B, Abbasguliyev H, Mutlu V, Mahmoudi Y, Dossa SAA, Mizan SR, Demirtas B, Cavus T, Yuksek A, Mazlum SS, Yelkenci C, Baran T, Satilmisoglu M, Sahin AZ, Kilinç A, Isik K, Yumurtaci Ö, Emin A, Girit Ç, Yildirak MK, Senyigit E, Güldag A, Söyleyici B, Aytin YE, Akay FE, Iskan NG, Mutlu B, Sunay AO, Ablett AD, Tie-Gill T, Ramsay G, De Paola L, McGuckin S, Alshakhs A, Ahmeidat A, Wong J, Goergen N, Ali Z, Mullarkey L, Bath MF, Walshe R, Lewis E, Berry B, Moneim J, Mookerjee S, Christy S, Ojofeitimi O, Carroll L, Hylands A, Delaugere LP, Reveendran D, Coulter C, Ralston C, Laverty L, Gallagher P, Ahmed A, Yeo YQ, Elliott D, Bennett J, Mcnamara M, Sivarajah S, Dunmore C, Aitken G, Nair M, Aly MH, Buari M, Farhan-Alanie MMH, Ahmed K, Sheikh Z, Monks M, Lehmann J, Rotimi O, Bell T, Limnatitou D, Gormley S, Taleongpong P, Patel V, Macgregor L, Amini S, Turner C, Dwyer-Hemmings L, Busuttil A, Powell J, Hensher C, Vivian F, Wcislo K, Millar Z, Hirosue S, Ogunmwonyi I, Nakakande D, Kwek I, Gaze H, Nirmalanantha A, Bin Amran AM, Foulkes A, Jones N, Pillai S, Khoury G, Powell T, Maleyko I, Sangheli A, Ransome M, Isse M, Aromolaran O, Bholah H, Anbarasan J, Rehman S, Hu E, Timms S, Reynolds W, Hotchkies A, Misra V, Suresh G, Murray V, Theocharidou L, Malik T, Janmohamed I, Carhart B, Khan A, Asif A, Hullait R, Quinn P, Rylance A, Butt S, Leathes J, Finch BJ, Philip Rajathasan T, Jeddy H, Kyaw HA, Wong N, Karelia S, Clements JM, Rainey M, Joshi N, Rahman A, Gallagher M, Rebuffa N, Abdelgalil R, Siaw Yen Lai R, Laurence N, Thomas S, Green C, Frostick R, Khera R, Povey M, Wong HL, McCusker C, Hlukha L, Pike G, Kamel F, Thakkar R, Donaldson C, Sequeira Campos M, Bhahirathan Y, Armitage MN, Hussain AS, Hardy B, Hassan Serry MY, Herron J, Bradbury M, Osunronbi T, Tam LYC, Khanan Kaabneh A, Lawther J, Fisher P, Tribedi T, Moosa A, Ramdin A, Goble M, Downs E, Wheldon L, Baggus E, Mandal A, Nayeem A, Ahmed S, Fradley W, Wilson C, Gallagher S, Criswell T, Ward J, Mukkavilli A, Stubbs B, Fordyce W, Suchdev N, Wei Lim S, Yi Tew Z, Sookramanien SR, Chan A, Bointas G, Paul M, Ward KL, Bagnall M, Pherwani SA, Wang K, Mitchell L, Heyworth J, Ayyar S, Obukofe R, Polson R, Mason D, Mackenzie E, Russell C, Doyle N, Habib Z, Zardab M, Sartaj F, Farooq H, Tabibi M, Drury DJ, James SJ, Barnett R, Teasdale AB, Richardson ETJ, Thomas DA, Ahmed S, Williams RL, Najabat-Lattif HF, Cahya E, Lou G, Coyle M, Homyer K, Zhu LY, Woods M, Chang J, O'Callaghan H, Suchett-Kaye I, Mihailidis TH, Alawattegama H, Seite E, Barrett A, Riordan E, Lam W, Dowdeswell M, Mulvenna C, Netke T, Awokoya O, Gurowich L, Dhera K, Hayat S, Williams L, Tincknell L, Spazzapan M, Teeling F, Sysum K, Latter J, Latter M, Khan S, Guruswamy M, Beedham W, Brazier E, Elghobashy M, Bajaj M, Mann H, Etel E, Woodmass M, Hayden H, Kisiel A, Ali Y, Husain S, Arnold A, Pedersen AC, Cunha P, Ahmed M, Al Zawawi S, Kudva V, Liu FY, Theodoropoulou K, Miscampbell M, Robinson AV, Johnston J, Dharni A, Lamb S, Westerman T, Evans E, Campbell L, Gillespie M, Cheong CM, Kulathevanayagam K, Varghese A, Ike SI, Chu TSM, Baljer B, Mogg JAW, Rai P, Claireaux HA, Williams M, Smillie R, Goetz J, Appleby E, Fadipe T, Vaughan-Burleigh S, Puri G, Hussain P, James P, Flather R, Cutler A, Pathak S, Sheldon J, Collicott T, al-Ausi M, Mondal A, Jovaisaite A, Shah SM, Khalid N, Gutmann D, Davison S, Alame YJ, Syed L, Owen WJ, Ahsan SD, Kalderon R, Anthony-Uzoeto U, Macleod Hall C, Zheng S, Wynter K, James C, Sapre D, Ghosh R, Baird J, Cockburn L, Blackwood O, Nadama HH, Simpson W, Jeong S, Bishop S, Bate R, Hobson C, Adam AH, Redclift C, Do J, Adeleye O, Poli F, Batterham A, Brown S, Parekh JN, Clay W, Pieri K, Jackson A, Brown S, Saxena A, Gurung B, Oyebola T, O'Brien F, Djeugam B, Gardezi S, Ul-Hasan S, Martin-Hernandez MP, Sisley M, Modi S, Antakia R, Elbayouk A, Soh YJ, Mather J, Yusuf Z, Al-Sarraf Z, Naja M, Rassool SB, Convill J, Nikookam Y, Warsame A, Tam JPH, Pace C, Kiandee M, Ridwan R, Carey C, Hirri F, McMillan MJA, Ling JJ, Powell-Chandler A, Pendelbury L, Kerimzade K, Tang A, Howard EO, Humayun S, Wadsworth OJ, Tan K, Abdelhameed F, Haglund C, Radnaeva I, Hu N, Rambhatla S, Waldron D, Madahar P, Malik S, Campbell A, Meney LC, Ibrahim I, Kang CK, Chiu JZJ, Livie V, Ibrahim B, Khalil M, Pooley G, Shishkin B, Gorgievska R, Docherty J, Southgate A, Coomes A, McGee F, Flanagan S, Thakrar C, Tan QJ, Anwar H, Clough R, Chrisp B, Cassels J, Cross GWV, Ragavoodoo A, Mercer L, Mercer C, Refalo A, Hadley R, McTighe A, Farrow F, Brodie A, Davis G, Shah DR, Bowers C, Patel S, Morice O, Burzic A, Cheung J, Shashidhara A, Theodoraki G, Birk J, Ong A, Ng MPE, Wong RTW, Maese S, Yeap B, Iqbal Z, Rojoa DM, Cabaleiro Barciela C, Hussain M, Ruddy CM, Lindwe S, Qamar Y, Chuita S, Melaugh T, Hall JD, Palmer C, Kouli O, Hassane ASI, Azhar AW, Tan TK, Perchard W, Scurr T, Davidson K, Campbell E, Kelk L, Ghosh A, Gibbins A, Mala D, Loizidou A, Hall O, Mecia L, Hew C, Varathan K, Tong L, Chandrasekar B, Giacci L, Buchanan E, O'Connell M, Kwak SY, Ong EH, Gardner S, Lim J, Maden C, Illahi M, Hale J, Xuan Tan Z, Edwards S, Stahl R, Stahl J, Hickman A, Collett D, Goolam-Mahomed Z, Allen B, Atiyah A, Ahmad H, Jones J, McGregor O, Ogundiya E, Gan FW, Boulbadaoui A, Kirnon-Jackman O, Lim QX, Peckham H, Yeoh T, Yong SQ, Chen JY, Siva S, Sam ZH, Gilani M, Goh YN, Muthukumar MG, Phillips S, Makin-Taylor R, Tjoakarfa J, Giri A, Suresan S, Thavayogan R, Hey CY, Thomas P, Johnson TA, Williams RI, Rashid A, Kushairi A, Rais A, James A, Bugelli M, Chechelnitskaya Y, Sandhu N, Toh C, Tandon R, Gray M, Kumar A, Ciurleo C, Nyamali I, Hiremath S, Sinha S, Chowdhary M, Bradley E, McTiernan M, Macdonald S, Sharkey S, McLaughlin N, Amey C, Kraria L, Skan O, Kind C, Findlay JM, Tupper P, Van Rhee C, Honeyman SI, Menon G, Ahmed M, Jegatheeswaran L, Griffiths N, Madhavan A, Warne M, Malcolm FL, Lessware T, Wilkerson HT, Chatterjee-Woolman S, Yoong A, Ahmed WUR, Longshaw A, Flannery O, Green R, Leaning M, Cragg J, Sharriff H, Doherty C, Ganesananthan S, Kwan KWL, Sanders-Crook L, Bhatia S, Eames S, Lewis F, Kirupananthan P, Boh ZY, Dass S, Soma A, Newton A, Hill M, Shafiq Y, Brkljac M, Boyce L, Jasionowska S, English WJ, Lam S, Chipeta C, Yilmaz D, Jain C, Garofalidou T, Novotny SA, Locke S, Bowman C, Begaj A, Murphy C, Radcliffe K, Chong JT, Poustie M, Jeffrey E, Chaudhury N, Rajendran K, Akbar Z, Walters B, Kulendrarajah B, Tran N, Shrestha S, Parmar S, Gallagher C, Hennessy L, Pentti E, Badhrinarayanan S, Fung A, Mansoor M, Kenny R, Kan P, Lee DE, Khosla S, Samake M, Shaban F, Aftab R, Gough M, Woodburn B, Vayalapra S, McMurrugh K, Wong C, Jimulia D, Deol S, Pike S, Embury-Young Y, Turner T, Patel M, Kilgallon E, Keating R, Walsh A, Khan H, Logue G, Orekoya M, Alasmar M, Charalambides M, Clavé Llavall A, Williamson E, Bharwada Y, Zearmal S, Evans H, Panikkar M, Cruz G, Caplan J, Ruparelia A, Tanvir T, Soare C, Pang YL, Trotter J, Zaidi A, Thakrar V, Pulickal P, Ahmed H, Parnell J, Khan H, Lennock S, Ford V, Pyc W, Brignall R, O'Neill D, Hanna R, Kane R, Nicola M, Rajput K, Xiao Y, Warner C, Michael S, Wright E, Juniper S, Thompson E, Hoskyns L, Kanitkar A, Ross C, Unsworth A, Rshaidat H, Demarre K, Chiang A, Bareh A, Dellen J, Faqihinejad C, Gadhvi A, Grant R, Lewsey J, Morris A, Martin H, McClarty C, Sanyal S, Alsaif A, Palkhi A, Bhopal S, Vishnu K S, Papanikolaou A, Mitra A, Nur A, Ali F, Burford C, Huq T, Sloper W, Irwin E, Matthews L, Ngu WS, Hosfield T, Muneeb F, Page O, Zeb E, Coey J, Al-Azzawi A, McIntosh J, Vucicevic A, Hughes M, Brooks L, Fanibi B, Dixon M, Njoku P, Morris D, Jobson J, Chowdhury H, Alawode DOT, Wynell-Mayow W, Udayachandran V, Alsoof D, Ekert J, Joseph N, Zulkefley N, Hunt G, Christodoulou T, Wright O, Soman S, Jamal M, Beqiri S, Borgas P, Christie S, Pereira F, Browne S, Yiu J, Dworkin A, Brayley J, Palmer A, Charalambos M, Jones CJ, Toner S, Cowden R, Lee L, Nicol P, Holman O, Imtiaz M, Albert V, Leung SP, Erotocritou M, Wong J, Stroud R, Mason D, Wilkin R, Thomson W, Mackee L, G N, Bei Y, Sait S, Mckenna Favier S, Ibrahim A, Kler A, Reynolds L, Mohamed SH, Majeed Y, Fakim B, Jones A, Kowal M, Liversedge G, Carrington Z, Windebank J, Izzarina A, Akbani U, Craven J, Aldarragi A, Harding S, Millward A, Shortland TC, Bedford M, Stroud R, Obukofe R, Mackenzie E, Gopalan V, Midgen A, Khadka P, Cheng O, Taneja S, Manobharath N, Kok JY, Lim DWE, Buick T, Boland M, Piya S, Devlin R, Fairfield CJ, George RJ, Rahi M, Zaman S, Hajiev S, Ross T, Owen M, Crisp E, Thompson C, Charalambous A, Hollywood JL, Saiyed A, Hammond RFL, Matthews J, Mendonca V, Spinty J, Khan K, Cheng J, Glynn N, Muhammad U, Khan M, Anderson L, Mccormack K, Mak J, Patrawala S, Milinkovic N, Schofield R, Chauhan M, Hartley L, Hind J, Ashworth I, Nelson L, Ratnasingham D, Akbari K, Whitehead T, Dimitriadis S, Marshall K, Flint EJ, Curran M, Horner C, Heybourne A, Morgan H, Wickstone C, Panagiotou D, O'Connell E, Dean K, Iqbal R, Walsh L, Yu N, Rana N, Massie E, Ng J, Jung M, Lee YD, Harris M, White S, Delibegovic S, Boev B, Tonchev P, Prochazka V, Örhalmi J, Riško J, Skalický A, Chrz K, Ravn S, Ojakäär A, Duchalais E, Dörr-Harim C, Herrle F, Koutserimpas C, Giraudo G, Armellini A, Ruzzenente A, Mazzeo C, De Padua C, Realis Luc A, Maroli A, Giani I, Cufari ME, Vitali M, Ceccarelli G, Gusai GP, Quattromani R, Virgilio E, Berti S, Mulas S, Di Mola FF, Papagni V, Tuminello F, Magnoli M, Vittori L, Longheu A, Loche GA, Braccio B, De Luca E, Resta G, Ancans G, Tamosiunas A, Petrulionis M, Andrejevic P, Stellingwerf ME, Abdulrahman N, Pas KGH, Thomas G, Brandsma AM, Davids J, Rottier SJ, Roy van Zuidewijn D, Hawkins R, Ong HI, Li Y, Desmond B, Winstanley J, Martins M, Rosete M, Americano M, Santos M, Frade S, Senhorinho R, Peixoto R, Alagoa João A, Alves-Vale C, Lamas M, O'Connor DB, Hoo M, Gopaul A, Scanlon K, O'Dwyer N, Negoi I, Jovanović M, Panyko A, De Lima H, Van Vuuren S, Curchod P, Gaspar S, Imadalou L, Mutlu D, Akyol C, Uygur FA, Eray IC, Biyiklioglu O, Çetin MF, Isik AE, Karip B, Dogan H, Sarıgül L, Tunc E, Aydin T, Bodur S, Karabulut K, Francis AA, Al-hadithi A, To N, Lau ISF, Smith E, Mahapatra S, McAuliffe O, Francis AA, Imam L, Akram B, Hossaini S, Davies R, Ko M, Collins J, Pandya A, Reilly S, Archer J, Auty C, Roche CD, Livie J, Chaudhry FA, Ntakomyti E, Diallo R, Bylinski T, Wright J, Lawday S, Masiha E, Tung J, Shirazi B, Neilson A, Epton S, Patel N, Trussell S, Couldrey A, Donnelly C, Eftychiou S. Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery. Br J Surg 2020; 107:e161-e169. [PMID: 31595986 DOI: 10.1002/bjs.11326] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Revised: 05/06/2019] [Accepted: 07/04/2019] [Indexed: 02/05/2023]
Abstract
BACKGROUND Ileus is common after elective colorectal surgery, and is associated with increased adverse events and prolonged hospital stay. The aim was to assess the role of non-steroidal anti-inflammatory drugs (NSAIDs) for reducing ileus after surgery. METHODS A prospective multicentre cohort study was delivered by an international, student- and trainee-led collaborative group. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The primary outcome was time to gastrointestinal recovery, measured using a composite measure of bowel function and tolerance to oral intake. The impact of NSAIDs was explored using Cox regression analyses, including the results of a centre-specific survey of compliance to enhanced recovery principles. Secondary safety outcomes included anastomotic leak rate and acute kidney injury. RESULTS A total of 4164 patients were included, with a median age of 68 (i.q.r. 57-75) years (54·9 per cent men). Some 1153 (27·7 per cent) received NSAIDs on postoperative days 1-3, of whom 1061 (92·0 per cent) received non-selective cyclo-oxygenase inhibitors. After adjustment for baseline differences, the mean time to gastrointestinal recovery did not differ significantly between patients who received NSAIDs and those who did not (4·6 versus 4·8 days; hazard ratio 1·04, 95 per cent c.i. 0·96 to 1·12; P = 0·360). There were no significant differences in anastomotic leak rate (5·4 versus 4·6 per cent; P = 0·349) or acute kidney injury (14·3 versus 13·8 per cent; P = 0·666) between the groups. Significantly fewer patients receiving NSAIDs required strong opioid analgesia (35·3 versus 56·7 per cent; P < 0·001). CONCLUSION NSAIDs did not reduce the time for gastrointestinal recovery after colorectal surgery, but they were safe and associated with reduced postoperative opioid requirement.
Collapse
|
45
|
Liu VY, Lin TY, Schrier W, Allen M, Singh P. AccuMeter noninstrumented quantitative assay of high-density lipoprotein in whole blood. Clin Chem 2019. [DOI: 10.1093/clinchem/39.9.1948] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
A novel noninstrumented technology (ChemTrak AccuMeter) for the quantitative measurement of analytes in biological fluids was reported at the 1990 Oak Ridge Conference (Clin Chem 1990;36:1591-7). This instrument-free technology has been adapted for the quantitative measurement of high-density lipoprotein (HDL). An in situ lipoprotein separation method has been developed and incorporated into the test for HDL determination. The sensitivity of the assay system has been adjusted so that HDL is measured over a clinically significant range of 250 to 1000 mg/L. This compares to a range of 1000 to 4000 mg/L for the total cholesterol in the earlier reported assay. Like the AccuMeter total cholesterol test, the Accumeter HDL test system is self-contained and consolidates blood separation, lipoprotein separation, and specimen measurement into a single step. The test procedure is simple, and the results are accurate.
Collapse
|
46
|
McMahon WA, Aleo VA, Schultz AM, Horter BL, Lindberg KG, Allen M, Anderson L, Barnes R, Bellow S, Bokina C, Boulter T, Caulkins L, Ceizyk M, Chavey C, Eastep Y, Gohil V, Guha S, Hall G, Hopkins K, Horter B, Kaufer A, Kaur D, Kim S, Kupski B, Lee J, Lester; T, Musch S, Silbernagel K, Sorce L, Steiner G, Sumpter R, Sutton J, Veach J. 3M™ Petrifilm™ Staph Express Count Plate Method for the Enumeration of Staphylococcus aureus in Selected Types of Meat, Seafood, and Poultry: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/86.5.947] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
The 3M™ Petrifilm™ Staph Express Count plate method was compared with AOAC Official Method 975.55 for the enumeration of Staphylococcus aureus in selected foods. Four foods—cooked, diced chicken; cured ham; smoked salmon; and pepperoni—were analyzed for S. aureus by 12 collaborating laboratories. For each food tested, the collaborators received 8 blind test samples consisting of a control sample, a low inoculation level, a medium inoculation level, and a medium inoculation level with background flora, each in duplicate. The mean log10 counts for the methods were comparable for all 4 foods. The repeatability and reproducibility variances of the 24 h Petrifilm Staph Express Count plate method were similar to those of the 72 h standard method.
Collapse
|
47
|
Gangar V, Curiale MS, D’Onorio A, Schultz A, Johnson RL, Atrache V, Agin J, Allen M, Armstrong T, Chaney T, Chang P, Chavey C, Clark T, Clover J, Cook P, Copeland F, Courtney T, Davis B, D’Onorio A, Downs D, Fender M, Foster T, Fox W, Hagen H, Hall C, High E, Kalik M, Kallstrom C, Keith M, Kruegel W, Lee J, Lewus C, Light D, Lindgren S, Mills J, Minor J, Murphy M, Muzzy T, Raghubeer E, Robbins R, Salinitro A, Saunders L, Sayer T, Schultz A, Sumpter R, Traux T, Vought K, Witt J, Yonker D. VIDAS® Enzyme-Linked Immunofluorescent Assay for Detection of Listeria in Foods: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/83.4.903] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
The VIDAS LIS method and the traditional culture methods for detection of Listeria species in food were evaluated in a multilaboratory comparative study. The 6 foods tested were either naturally contaminated or inoculated with 3 different concentrations of Listeria. Results for each food and each contamination level with the VIDAS LIS method were as good as or better than those obtained with the traditional culture method. Of 1558 samples tested, 935 were positive: 839 by the VIDAS method and 809 by standard culture methods. Overall false negative rates were 10.3 and 13.5% for the VIDAS LIS and culture methods, respectively. The false positive rate for the VIDAS LIS assay was 1.4% based on 9 VIDAS LIS positive assays that did not confirm positive by isolation of Listeria. The agreement between the VIDAS LIS and culture methods for all samples tested was 86%.
Collapse
|
48
|
Pantaleo G, Janes H, Karuna S, Grant S, Ouedraogo GL, Allen M, Tomaras GD, Frahm N, Montefiori DC, Ferrari G, Ding S, Lee C, Robb ML, Esteban M, Wagner R, Bart PA, Rettby N, McElrath MJ, Gilbert PB, Kublin JG, Corey L. Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial. Lancet HIV 2019; 6:e737-e749. [PMID: 31601541 PMCID: PMC7156919 DOI: 10.1016/s2352-3018(19)30262-0] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Revised: 06/20/2019] [Accepted: 07/19/2019] [Indexed: 01/06/2023]
Abstract
BACKGROUND Up to now, immunisation regimens that have been assessed for development of HIV vaccines have included purified envelope (Env) protein among the boosting components of the regimen. We postulated that co-administration of Env protein with either a DNA or NYVAC vector during priming would result in early generation of antibody responses to the Env V1/V2 region, which are important markers for effective protection against infection. We aimed to assess the safety and immunogenicity of a multivalent HIV vaccine including either DNA or NYVAC vectors alone or in combination with Env glycoprotein (gp120) followed by a co-delivered NYVAC and Env protein boost. METHODS We did a single-centre, double-blind, placebo-controlled phase 1b trial at the Centre Hospitalier Universitaire Vaudois (Lausanne, Switzerland). We included healthy volunteers aged 18-50 years who were at low risk of HIV infection. We randomly allocated participants using computer-generated random numbers to one of four vaccination schedules or placebo (4:1), and within these schedules participants were allocated either active treatment (T1, T2, T3, and T4) or placebo (C1, C2, C3, and C4). T1 consisted of two doses of NYVAC vector followed by two doses of NYVAC vector and gp120 Env protein; T2 comprised four doses of NYVAC vector and gp120 Env protein; T3 was two doses of DNA vector followed by two doses of NYVAC vector and gp120 Env protein; and T4 was two doses of DNA vector and gp120 Env protein followed by two doses of NYVAC vector and gp120 Env protein. Placebo injections were matched to the corresponding active treatment group. Doses were administered by injection at months 0, 1, 3, and 6. Primary outcomes were safety and immunogenicity of the vaccine schedules. Immune response measures included cross-clade and epitope-specific binding antibodies, neutralising antibodies, and antibody-dependent cell-mediated cytotoxicity measured 2 weeks after the month 1, 3, and 6 vaccinations. This trial is registered with ClinicalTrials.gov, NCT01799954. FINDINGS Between Aug 23, 2012, and April 18, 2013, 148 healthy adult volunteers were screened for the trial, of whom 96 participants were enrolled. 20 individuals were allocated to each active treatment group (groups T1-4; n=80) and four were assigned to each placebo group (groups C1-4; n=16). Vaccines containing the NYVAC vector (groups T1 and T2) were associated with more frequent severe reactogenicity and more adverse events than were vaccines containing the DNA vector (groups T3 and T4). The most frequent adverse events judged related to study product were lymphadenopathy (n=9) and hypoaesthesia (n=2). Two participants, one in the placebo group and one in the DNA-primed T3 group, had serious adverse events that were judged unrelated to study product. One participant in the T3 group died from cranial trauma after a motor vehicle accident. Across the active treatment groups, IgG responses 2 weeks after the 6-month dose of vaccine were 74-95%. Early administration of gp120 Env protein (groups T2 and T4) was associated with a substantially earlier and higher area under the curve for gp120 Env binding, production of anti-V1/V2 and neutralising antibodies, and better antibody-response coverage over a period of 18 months, compared with vaccination regimens that delayed administration of gp120 Env protein until the 3-month vaccination (groups T1 and T3). INTERPRETATION Co-administration of gp120 Env protein components with DNA or NYVAC vectors during priming led to early and potent induction of Env V1/V2 IgG binding antibody responses. This immunisation approach should be considered for induction of preventive antibodies in future HIV vaccine efficacy trials. FUNDING National Institutes of Health, National Institute of Allergy and Infectious Diseases, and the Bill & Melinda Gates Foundation.
Collapse
|
49
|
Battisti N, Lee K, Shepherd S, Rogerson F, Mohammed K, Allen M, Ring A. Safety and efficacy of T-DM1 in 128 patients with advanced HER2+ breast cancer: The Royal Marsden experience. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz242.050] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
50
|
Intabli H, Flint M, Qattan A, Allen M, Yeoman M. The effect of cortisol on methylation patterns in breast cancer cell lines. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz238.042] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|